{
    "medicine_id": "472a15627d134f7b04bdfccd9e916cf20b2a57c4",
    "platform_id": "DB08870",
    "metadata": {
        "name": "Adcetris 50 mg Injection powder for solution",
        "composition": "50 mg Brentuximab vedotin",
        "clinical_particulars": {
            "therapeutic_indications": "Seattle Genetics Announced FDA Approval of ADCETRIS Brentuximab Vedotin in combination with chemotherapy for adults with previously untreated stage III or IV Classical Hodgkin Lymphoma in March 2018 L1737 L1739 Hodgkin lymphoma after failure of autologous stem cell transplant ASCT or after failure of at least two prior multi agent chemotherapy regimens in patients who are not ASCT candidates FDA label L1737 Systemic anaplastic large cell lymphoma after failure of at least one prior multi agent chemotherapy regimen FDA label",
            "contraindications": {
                "disease": "The most severe toxic reaction seen in patients is progressive multifocal leukoencephalopathy FDA label Progressive multifocal leukoencephalopathy PML follows infection by the JC virus which is not related to Creutzfeldt Jakob disease Symptoms of this condition begin insidiously and usually worsen progressively The symptoms vary depending on which region of the brain is infected In about two out of three patients mental function deteriorates rapidly leading to dementia Speaking and walking may become increasingly difficult Vision may be impaired and total blindness may occur Rarely headaches and seizures can occur mainly in immunocompromised patients The most serious sequela of this condition is death L1743 Common adverse effects of Adcetris may include neutropenia anemia peripheral neuropathy nausea fatigue constipation diarrhea vomiting and fever In one trial neutropenia occurred in 91 percent of patients treated with Adcetris plus chemotherapy which was associated with a 19 percent rate of febrile neutropenia neutropenia and fever L1737 Preventive treatment with G CSF a growth factor for the bone marrow to produce white blood cells is recommended with Adcetris plus chemotherapy for the first line treatment of Stage III or IV cHL L1737 Adcetris has a boxed warning that emphasizes the risk of John Cunningham virus infection leading to progressive multifocal leukoencephalopathy or PML a rare but serious brain infection that may be lethal Serious risks of Adcetris include peripheral neuropathy severe allergic anaphylaxis or infusion site reactions damage to the blood lungs and liver hematologic pulmonary and hepato toxicities severe opportunistic infections metabolic abnormalities tumor lysis syndrome dermatologic reactions and gastrointestinal complications Adcetris may cause harm to the fetus and newborn baby women should be warned of the potential risk to the fetus and to use effective contraception and to avoid breastfeeding while taking Adcetris L1737 MMAE was found to be genotoxic in the rat bone marrow micronucleus study through an aneugenic mechanism This effect is consistent with the pharmacological effect of MMAE as a microtubule disrupting drug Fertility studies with Brentuximab vedotin or MMAE have not been conducted Despite this results of repeat dose toxicity studies in rats suggest the potential for Brentuximab vedotin to have a negative effect on male reproductive function and fertility In a 4 week repeated dose toxicity study in rats with weekly dosing at 0 5 5 or 10 mg kg brentuximab vedotin seminiferous tubule degeneration Sertoli cell vacuolation reduced spermatogenesis and aspermia were observed L1737 Effects in animals were seen mostly at 5 and 10 mg kg doses of brentuximab vedotin These dosages are approximately 3 and 6 fold the human recommended dose of 1 8 mg kg respectively based on individual body weight FDA label",
                "pregnancy": "NA",
                "machine_ops": "NA",
                "pharmacodynamics": "Brentuximab vedotin causes apoptosis of tumor cells by preventing cell cycle progression of the G2 to M phase through disruption of the cytosolic microtuble network thus preventing tumor growth and proliferation FDA label Hodgkin lymphoma HL is characterized by malignant Reed Sternberg cells which express CD30 a marker of large cell lymphoma A32159 Until March 2018 USA National Comprehensive Cancer Network guidelines for patients with advanced HL stage III IV disease recommend treatment with adriamycin bleomycin vinblastine and dacarbazine ABVD or escalated bleomycin etoposide adriamycin cyclophosphamide vincristine procarbazine and prednisone BEACOPP as first line regimens L1740 ABVD appears to be as effective with fewer side effects as escalated BEACOPP Escalated BEACOPP leads to a greater progression free survival but no difference in overall survival Recent progress in technology has enabled a new shift to cancer therapy targeting specific molecules Brentuximab vedotin a CD30 directed antibody conjugate selectively targets malignant HL cells A32158 The effect of Brentuximab vedotin 1 8 mg kg on the QTc interval was studied in an open label single group study in 46 patients diagnosed with CD30 expressing hematologic malignancies Ingestion of brentuximab vedotin did not prolong the mean cardiac QTc interval 10 ms from baseline levels Smaller increases in the mean QTc interval 10 ms cannot be ruled out because this study did not include a placebo arm and a positive control arm FDA label",
                "excipients": "NA",
                "incompatibilities": [
                    {
                        "drugbank-id": "DB06643",
                        "description": "The risk or severity of adverse effects can be increased when Denosumab is combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB00008",
                        "description": "The risk or severity of adverse effects can be increased when Peginterferon alfa 2a is combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB00011",
                        "description": "The risk or severity of adverse effects can be increased when Interferon alfa n1 is combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB00018",
                        "description": "The risk or severity of adverse effects can be increased when Interferon alfa n3 is combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB00022",
                        "description": "The risk or severity of adverse effects can be increased when Peginterferon alfa 2b is combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB00033",
                        "description": "The risk or severity of adverse effects can be increased when Interferon gamma 1b is combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB00034",
                        "description": "The risk or severity of adverse effects can be increased when Interferon alfa 2a Recombinant is combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB00056",
                        "description": "The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB00059",
                        "description": "The risk or severity of adverse effects can be increased when Pegaspargase is combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB00068",
                        "description": "The risk or severity of adverse effects can be increased when Interferon beta 1b is combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB00069",
                        "description": "The risk or severity of adverse effects can be increased when Interferon alfacon 1 is combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB00073",
                        "description": "The risk or severity of adverse effects can be increased when Rituximab is combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB00074",
                        "description": "The risk or severity of adverse effects can be increased when Basiliximab is combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB00075",
                        "description": "The risk or severity of adverse effects can be increased when Muromonab is combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB00078",
                        "description": "The risk or severity of adverse effects can be increased when Ibritumomab tiuxetan is combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB00081",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB00087",
                        "description": "The risk or severity of adverse effects can be increased when Alemtuzumab is combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB00092",
                        "description": "The risk or severity of adverse effects can be increased when Alefacept is combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB00095",
                        "description": "The risk or severity of adverse effects can be increased when Efalizumab is combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB00098",
                        "description": "The risk or severity of adverse effects can be increased when Antithymocyte immunoglobulin rabbit is combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB00105",
                        "description": "The risk or severity of adverse effects can be increased when Interferon alfa 2b is combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB00111",
                        "description": "The risk or severity of adverse effects can be increased when Daclizumab is combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB00112",
                        "description": "The risk or severity of adverse effects can be increased when Bevacizumab is combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB00120",
                        "description": "The risk or severity of adverse effects can be increased when Phenylalanine is combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB00242",
                        "description": "The risk or severity of adverse effects can be increased when Cladribine is combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB00262",
                        "description": "The risk or severity of adverse effects can be increased when Carmustine is combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB00291",
                        "description": "The risk or severity of adverse effects can be increased when Chlorambucil is combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB00293",
                        "description": "The risk or severity of adverse effects can be increased when Raltitrexed is combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB00305",
                        "description": "The risk or severity of adverse effects can be increased when Mitomycin is combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB00322",
                        "description": "The risk or severity of adverse effects can be increased when Floxuridine is combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB00352",
                        "description": "The risk or severity of adverse effects can be increased when Tioguanine is combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB00380",
                        "description": "The risk or severity of adverse effects can be increased when Dexrazoxane is combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB00432",
                        "description": "The risk or severity of adverse effects can be increased when Trifluridine is combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB00441",
                        "description": "The risk or severity of adverse effects can be increased when Gemcitabine is combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB00445",
                        "description": "The risk or severity of adverse effects can be increased when Epirubicin is combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB00480",
                        "description": "The risk or severity of adverse effects can be increased when Lenalidomide is combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB00488",
                        "description": "The risk or severity of adverse effects can be increased when Altretamine is combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB00495",
                        "description": "The risk or severity of adverse effects can be increased when Zidovudine is combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB00515",
                        "description": "The risk or severity of adverse effects can be increased when Cisplatin is combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB00526",
                        "description": "The risk or severity of adverse effects can be increased when Oxaliplatin is combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB00544",
                        "description": "The risk or severity of adverse effects can be increased when Fluorouracil is combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB00550",
                        "description": "The risk or severity of adverse effects can be increased when Propylthiouracil is combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB00552",
                        "description": "The risk or severity of adverse effects can be increased when Pentostatin is combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB00601",
                        "description": "The risk or severity of adverse effects can be increased when Linezolid is combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB00631",
                        "description": "The risk or severity of adverse effects can be increased when Clofarabine is combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB00642",
                        "description": "The risk or severity of adverse effects can be increased when Pemetrexed is combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB00687",
                        "description": "The risk or severity of adverse effects can be increased when Fludrocortisone is combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB00688",
                        "description": "The risk or severity of adverse effects can be increased when Mycophenolate mofetil is combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB00755",
                        "description": "The risk or severity of adverse effects can be increased when Tretinoin is combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB00795",
                        "description": "The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB00851",
                        "description": "The risk or severity of adverse effects can be increased when Dacarbazine is combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB00853",
                        "description": "The risk or severity of adverse effects can be increased when Temozolomide is combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB00859",
                        "description": "The risk or severity of adverse effects can be increased when Penicillamine is combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB00888",
                        "description": "The risk or severity of adverse effects can be increased when Mechlorethamine is combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB00928",
                        "description": "The risk or severity of adverse effects can be increased when Azacitidine is combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB00958",
                        "description": "The risk or severity of adverse effects can be increased when Carboplatin is combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB00993",
                        "description": "The risk or severity of adverse effects can be increased when Azathioprine is combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB01005",
                        "description": "The risk or severity of adverse effects can be increased when Hydroxyurea is combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB01024",
                        "description": "The risk or severity of adverse effects can be increased when Mycophenolic acid is combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB01033",
                        "description": "The risk or severity of adverse effects can be increased when Mercaptopurine is combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB01041",
                        "description": "The risk or severity of adverse effects can be increased when Thalidomide is combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB01042",
                        "description": "The risk or severity of adverse effects can be increased when Melphalan is combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB01073",
                        "description": "The risk or severity of adverse effects can be increased when Fludarabine is combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB01099",
                        "description": "The risk or severity of adverse effects can be increased when Flucytosine is combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB01101",
                        "description": "The risk or severity of adverse effects can be increased when Capecitabine is combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB01168",
                        "description": "The risk or severity of adverse effects can be increased when Procarbazine is combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB01169",
                        "description": "The risk or severity of adverse effects can be increased when Arsenic trioxide is combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB01177",
                        "description": "The risk or severity of adverse effects can be increased when Idarubicin is combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB01206",
                        "description": "The risk or severity of adverse effects can be increased when Lomustine is combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB01257",
                        "description": "The risk or severity of adverse effects can be increased when Eculizumab is combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB01262",
                        "description": "The risk or severity of adverse effects can be increased when Decitabine is combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB01280",
                        "description": "The risk or severity of adverse effects can be increased when Nelarabine is combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB01410",
                        "description": "The risk or severity of adverse effects can be increased when Ciclesonide is combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB01423",
                        "description": "The risk or severity of adverse effects can be increased when Stepronin is combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB01816",
                        "description": "The risk or severity of adverse effects can be increased when Castanospermine is combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB02546",
                        "description": "The risk or severity of adverse effects can be increased when Vorinostat is combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB02806",
                        "description": "The risk or severity of adverse effects can be increased when 2 Methoxyethanol is combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB03523",
                        "description": "The risk or severity of adverse effects can be increased when Brequinar is combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB04951",
                        "description": "The risk or severity of adverse effects can be increased when Pirfenidone is combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB05258",
                        "description": "The risk or severity of adverse effects can be increased when Interferon alfa is combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB05259",
                        "description": "The risk or severity of adverse effects can be increased when Glatiramer is combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB05260",
                        "description": "The risk or severity of adverse effects can be increased when Gallium nitrate is combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB05459",
                        "description": "The risk or severity of adverse effects can be increased when Briakinumab is combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB05472",
                        "description": "The risk or severity of adverse effects can be increased when Human interferon omega 1 is combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB06612",
                        "description": "The risk or severity of adverse effects can be increased when Mepolizumab is combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB06662",
                        "description": "The risk or severity of adverse effects can be increased when Abetimus is combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB06681",
                        "description": "The risk or severity of adverse effects can be increased when Belatacept is combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB06769",
                        "description": "The risk or severity of adverse effects can be increased when Bendamustine is combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB06813",
                        "description": "The risk or severity of adverse effects can be increased when Pralatrexate is combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB08059",
                        "description": "The risk or severity of adverse effects can be increased when Wortmannin is combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB08871",
                        "description": "The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Eribulin"
                    },
                    {
                        "drugbank-id": "DB08879",
                        "description": "The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Belimumab"
                    },
                    {
                        "drugbank-id": "DB08880",
                        "description": "The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Teriflunomide"
                    },
                    {
                        "drugbank-id": "DB08908",
                        "description": "The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Dimethyl fumarate"
                    },
                    {
                        "drugbank-id": "DB08935",
                        "description": "The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Obinutuzumab"
                    },
                    {
                        "drugbank-id": "DB09033",
                        "description": "The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Vedolizumab"
                    },
                    {
                        "drugbank-id": "DB09052",
                        "description": "The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Blinatumomab"
                    },
                    {
                        "drugbank-id": "DB09077",
                        "description": "The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Dinutuximab"
                    },
                    {
                        "drugbank-id": "DB09082",
                        "description": "The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB09091",
                        "description": "The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Tixocortol"
                    },
                    {
                        "drugbank-id": "DB09122",
                        "description": "The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Peginterferon beta 1a"
                    },
                    {
                        "drugbank-id": "DB09312",
                        "description": "The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Antilymphocyte immunoglobulin horse"
                    },
                    {
                        "drugbank-id": "DB09378",
                        "description": "The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Fluprednisolone"
                    },
                    {
                        "drugbank-id": "DB11466",
                        "description": "The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Tepoxalin"
                    },
                    {
                        "drugbank-id": "DB11529",
                        "description": "The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Melengestrol"
                    },
                    {
                        "drugbank-id": "DB11569",
                        "description": "The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Ixekizumab"
                    },
                    {
                        "drugbank-id": "DB11580",
                        "description": "The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Ravulizumab"
                    },
                    {
                        "drugbank-id": "DB11616",
                        "description": "The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Pirarubicin"
                    },
                    {
                        "drugbank-id": "DB11693",
                        "description": "The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Voclosporin"
                    },
                    {
                        "drugbank-id": "DB11708",
                        "description": "The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Peficitinib"
                    },
                    {
                        "drugbank-id": "DB11776",
                        "description": "The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Brodalumab"
                    },
                    {
                        "drugbank-id": "DB11803",
                        "description": "The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Sirukumab"
                    },
                    {
                        "drugbank-id": "DB11834",
                        "description": "The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Guselkumab"
                    },
                    {
                        "drugbank-id": "DB12025",
                        "description": "The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Triptolide"
                    },
                    {
                        "drugbank-id": "DB12612",
                        "description": "The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Ozanimod"
                    },
                    {
                        "drugbank-id": "DB12617",
                        "description": "The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Mizoribine"
                    },
                    {
                        "drugbank-id": "DB12692",
                        "description": "The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Gusperimus"
                    },
                    {
                        "drugbank-id": "DB12814",
                        "description": "The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Cepeginterferon alfa 2B"
                    },
                    {
                        "drugbank-id": "DB12902",
                        "description": "The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Trofosfamide"
                    },
                    {
                        "drugbank-id": "DB12947",
                        "description": "The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Doxifluridine"
                    },
                    {
                        "drugbank-id": "DB12991",
                        "description": "The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Deoxyspergualin"
                    },
                    {
                        "drugbank-id": "DB12996",
                        "description": "The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Acteoside"
                    },
                    {
                        "drugbank-id": "DB13014",
                        "description": "The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Hypericin"
                    },
                    {
                        "drugbank-id": "DB13068",
                        "description": "The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with 9 N methyl L isoleucine cyclosporin A"
                    },
                    {
                        "drugbank-id": "DB13223",
                        "description": "The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Fluocortin"
                    },
                    {
                        "drugbank-id": "DB13241",
                        "description": "The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Begelomab"
                    },
                    {
                        "drugbank-id": "DB13491",
                        "description": "The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Fluperolone"
                    },
                    {
                        "drugbank-id": "DB13856",
                        "description": "The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Fluclorolone"
                    },
                    {
                        "drugbank-id": "DB14219",
                        "description": "The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Monomethyl fumarate"
                    },
                    {
                        "drugbank-id": "DB14762",
                        "description": "The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Risankizumab"
                    },
                    {
                        "drugbank-id": "DB14919",
                        "description": "The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Rozanolixizumab"
                    },
                    {
                        "drugbank-id": "DB15253",
                        "description": "The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Bleselumab"
                    },
                    {
                        "drugbank-id": "DB00276",
                        "description": "The risk or severity of adverse effects can be increased when Amsacrine is combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB00328",
                        "description": "The risk or severity of adverse effects can be increased when Indomethacin is combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB00428",
                        "description": "The risk or severity of adverse effects can be increased when Streptozocin is combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB00635",
                        "description": "The risk or severity of adverse effects can be increased when Prednisone is combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB00970",
                        "description": "The risk or severity of adverse effects can be increased when Dactinomycin is combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB01196",
                        "description": "The risk or severity of adverse effects can be increased when Estramustine is combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB01611",
                        "description": "The risk or severity of adverse effects can be increased when Hydroxychloroquine is combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB04630",
                        "description": "The risk or severity of adverse effects can be increased when Aldosterone is combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB14066",
                        "description": "The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Tetrandrine"
                    },
                    {
                        "drugbank-id": "DB00987",
                        "description": "The risk or severity of adverse effects can be increased when Cytarabine is combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB01108",
                        "description": "The risk or severity of adverse effects can be increased when Trilostane is combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB05015",
                        "description": "The risk or severity of adverse effects can be increased when Belinostat is combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB00547",
                        "description": "The risk or severity of adverse effects can be increased when Desoximetasone is combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB00324",
                        "description": "The risk or severity of adverse effects can be increased when Fluorometholone is combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB00108",
                        "description": "The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Natalizumab"
                    },
                    {
                        "drugbank-id": "DB00337",
                        "description": "The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB01656",
                        "description": "Roflumilast may increase the immunosuppressive activities of Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB06688",
                        "description": "The therapeutic efficacy of Sipuleucel T can be decreased when used in combination with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB00012",
                        "description": "The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB00016",
                        "description": "The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB08894",
                        "description": "The risk or severity of Thrombosis can be increased when Peginesatide is combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB09107",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB00745",
                        "description": "The metabolism of Brentuximab vedotin can be increased when combined with Modafinil"
                    },
                    {
                        "drugbank-id": "DB06413",
                        "description": "The metabolism of Brentuximab vedotin can be increased when combined with Armodafinil"
                    },
                    {
                        "drugbank-id": "DB08889",
                        "description": "The serum concentration of Carfilzomib can be increased when it is combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB00196",
                        "description": "The serum concentration of Brentuximab vedotin can be increased when it is combined with Fluconazole"
                    },
                    {
                        "drugbank-id": "DB00199",
                        "description": "The serum concentration of Brentuximab vedotin can be increased when it is combined with Erythromycin"
                    },
                    {
                        "drugbank-id": "DB00203",
                        "description": "The serum concentration of Brentuximab vedotin can be increased when it is combined with Sildenafil"
                    },
                    {
                        "drugbank-id": "DB00206",
                        "description": "The serum concentration of Brentuximab vedotin can be increased when it is combined with Reserpine"
                    },
                    {
                        "drugbank-id": "DB00243",
                        "description": "The serum concentration of Brentuximab vedotin can be increased when it is combined with Ranolazine"
                    },
                    {
                        "drugbank-id": "DB00398",
                        "description": "The serum concentration of Brentuximab vedotin can be increased when it is combined with Sorafenib"
                    },
                    {
                        "drugbank-id": "DB00408",
                        "description": "The serum concentration of Brentuximab vedotin can be increased when it is combined with Loxapine"
                    },
                    {
                        "drugbank-id": "DB00468",
                        "description": "The serum concentration of Brentuximab vedotin can be increased when it is combined with Quinine"
                    },
                    {
                        "drugbank-id": "DB00539",
                        "description": "The serum concentration of Brentuximab vedotin can be increased when it is combined with Toremifene"
                    },
                    {
                        "drugbank-id": "DB00641",
                        "description": "The serum concentration of Brentuximab vedotin can be increased when it is combined with Simvastatin"
                    },
                    {
                        "drugbank-id": "DB00661",
                        "description": "The serum concentration of Brentuximab vedotin can be increased when it is combined with Verapamil"
                    },
                    {
                        "drugbank-id": "DB00675",
                        "description": "The serum concentration of Brentuximab vedotin can be increased when it is combined with Tamoxifen"
                    },
                    {
                        "drugbank-id": "DB00834",
                        "description": "The serum concentration of Brentuximab vedotin can be increased when it is combined with Mifepristone"
                    },
                    {
                        "drugbank-id": "DB00872",
                        "description": "The serum concentration of Brentuximab vedotin can be increased when it is combined with Conivaptan"
                    },
                    {
                        "drugbank-id": "DB00908",
                        "description": "The serum concentration of Brentuximab vedotin can be increased when it is combined with Quinidine"
                    },
                    {
                        "drugbank-id": "DB00909",
                        "description": "The serum concentration of Brentuximab vedotin can be increased when it is combined with Zonisamide"
                    },
                    {
                        "drugbank-id": "DB00932",
                        "description": "The serum concentration of Brentuximab vedotin can be increased when it is combined with Tipranavir"
                    },
                    {
                        "drugbank-id": "DB01026",
                        "description": "The serum concentration of Brentuximab vedotin can be increased when it is combined with Ketoconazole"
                    },
                    {
                        "drugbank-id": "DB01118",
                        "description": "The serum concentration of Brentuximab vedotin can be increased when it is combined with Amiodarone"
                    },
                    {
                        "drugbank-id": "DB01136",
                        "description": "The serum concentration of Brentuximab vedotin can be increased when it is combined with Carvedilol"
                    },
                    {
                        "drugbank-id": "DB01167",
                        "description": "The serum concentration of Brentuximab vedotin can be increased when it is combined with Itraconazole"
                    },
                    {
                        "drugbank-id": "DB01182",
                        "description": "The serum concentration of Brentuximab vedotin can be increased when it is combined with Propafenone"
                    },
                    {
                        "drugbank-id": "DB01211",
                        "description": "The serum concentration of Brentuximab vedotin can be increased when it is combined with Clarithromycin"
                    },
                    {
                        "drugbank-id": "DB01232",
                        "description": "The serum concentration of Brentuximab vedotin can be increased when it is combined with Saquinavir"
                    },
                    {
                        "drugbank-id": "DB01259",
                        "description": "The serum concentration of Brentuximab vedotin can be increased when it is combined with Lapatinib"
                    },
                    {
                        "drugbank-id": "DB01267",
                        "description": "The serum concentration of Brentuximab vedotin can be increased when it is combined with Paliperidone"
                    },
                    {
                        "drugbank-id": "DB01388",
                        "description": "The serum concentration of Brentuximab vedotin can be increased when it is combined with Mibefradil"
                    },
                    {
                        "drugbank-id": "DB04851",
                        "description": "The serum concentration of Brentuximab vedotin can be increased when it is combined with Biricodar"
                    },
                    {
                        "drugbank-id": "DB04855",
                        "description": "The serum concentration of Brentuximab vedotin can be increased when it is combined with Dronedarone"
                    },
                    {
                        "drugbank-id": "DB04868",
                        "description": "The serum concentration of Brentuximab vedotin can be increased when it is combined with Nilotinib"
                    },
                    {
                        "drugbank-id": "DB04881",
                        "description": "The serum concentration of Brentuximab vedotin can be increased when it is combined with Elacridar"
                    },
                    {
                        "drugbank-id": "DB04908",
                        "description": "The serum concentration of Brentuximab vedotin can be increased when it is combined with Flibanserin"
                    },
                    {
                        "drugbank-id": "DB05294",
                        "description": "The serum concentration of Brentuximab vedotin can be increased when it is combined with Vandetanib"
                    },
                    {
                        "drugbank-id": "DB05521",
                        "description": "The serum concentration of Brentuximab vedotin can be increased when it is combined with Telaprevir"
                    },
                    {
                        "drugbank-id": "DB06191",
                        "description": "The serum concentration of Brentuximab vedotin can be increased when it is combined with Zosuquidar"
                    },
                    {
                        "drugbank-id": "DB06240",
                        "description": "The serum concentration of Brentuximab vedotin can be increased when it is combined with Tariquidar"
                    },
                    {
                        "drugbank-id": "DB06287",
                        "description": "The serum concentration of Brentuximab vedotin can be increased when it is combined with Temsirolimus"
                    },
                    {
                        "drugbank-id": "DB06290",
                        "description": "The serum concentration of Brentuximab vedotin can be increased when it is combined with Simeprevir"
                    },
                    {
                        "drugbank-id": "DB06636",
                        "description": "The serum concentration of Brentuximab vedotin can be increased when it is combined with Isavuconazonium"
                    },
                    {
                        "drugbank-id": "DB07348",
                        "description": "The serum concentration of Brentuximab vedotin can be increased when it is combined with Brefeldin A"
                    },
                    {
                        "drugbank-id": "DB08816",
                        "description": "The serum concentration of Brentuximab vedotin can be increased when it is combined with Ticagrelor"
                    },
                    {
                        "drugbank-id": "DB08820",
                        "description": "The serum concentration of Brentuximab vedotin can be increased when it is combined with Ivacaftor"
                    },
                    {
                        "drugbank-id": "DB08827",
                        "description": "The serum concentration of Brentuximab vedotin can be increased when it is combined with Lomitapide"
                    },
                    {
                        "drugbank-id": "DB08881",
                        "description": "The serum concentration of Brentuximab vedotin can be increased when it is combined with Vemurafenib"
                    },
                    {
                        "drugbank-id": "DB08882",
                        "description": "The serum concentration of Brentuximab vedotin can be increased when it is combined with Linagliptin"
                    },
                    {
                        "drugbank-id": "DB08893",
                        "description": "The serum concentration of Brentuximab vedotin can be increased when it is combined with Mirabegron"
                    },
                    {
                        "drugbank-id": "DB08896",
                        "description": "The serum concentration of Brentuximab vedotin can be increased when it is combined with Regorafenib"
                    },
                    {
                        "drugbank-id": "DB08899",
                        "description": "The serum concentration of Brentuximab vedotin can be increased when it is combined with Enzalutamide"
                    },
                    {
                        "drugbank-id": "DB08901",
                        "description": "The serum concentration of Brentuximab vedotin can be increased when it is combined with Ponatinib"
                    },
                    {
                        "drugbank-id": "DB08907",
                        "description": "The serum concentration of Brentuximab vedotin can be increased when it is combined with Canagliflozin"
                    },
                    {
                        "drugbank-id": "DB08916",
                        "description": "The serum concentration of Brentuximab vedotin can be increased when it is combined with Afatinib"
                    },
                    {
                        "drugbank-id": "DB09027",
                        "description": "The serum concentration of Brentuximab vedotin can be increased when it is combined with Ledipasvir"
                    },
                    {
                        "drugbank-id": "DB09030",
                        "description": "The serum concentration of Brentuximab vedotin can be increased when it is combined with Vorapaxar"
                    },
                    {
                        "drugbank-id": "DB09034",
                        "description": "The serum concentration of Brentuximab vedotin can be increased when it is combined with Suvorexant"
                    },
                    {
                        "drugbank-id": "DB09048",
                        "description": "The serum concentration of Brentuximab vedotin can be increased when it is combined with Netupitant"
                    },
                    {
                        "drugbank-id": "DB09065",
                        "description": "The serum concentration of Brentuximab vedotin can be increased when it is combined with Cobicistat"
                    },
                    {
                        "drugbank-id": "DB09073",
                        "description": "The serum concentration of Brentuximab vedotin can be increased when it is combined with Palbociclib"
                    },
                    {
                        "drugbank-id": "DB09102",
                        "description": "The serum concentration of Brentuximab vedotin can be increased when it is combined with Daclatasvir"
                    },
                    {
                        "drugbank-id": "DB09239",
                        "description": "The serum concentration of Brentuximab vedotin can be increased when it is combined with Niguldipine"
                    },
                    {
                        "drugbank-id": "DB09280",
                        "description": "The serum concentration of Brentuximab vedotin can be increased when it is combined with Lumacaftor"
                    },
                    {
                        "drugbank-id": "DB09291",
                        "description": "The serum concentration of Brentuximab vedotin can be increased when it is combined with Rolapitant"
                    },
                    {
                        "drugbank-id": "DB11581",
                        "description": "The serum concentration of Brentuximab vedotin can be increased when it is combined with Venetoclax"
                    },
                    {
                        "drugbank-id": "DB11586",
                        "description": "The serum concentration of Brentuximab vedotin can be increased when it is combined with Asunaprevir"
                    },
                    {
                        "drugbank-id": "DB11613",
                        "description": "The serum concentration of Brentuximab vedotin can be increased when it is combined with Velpatasvir"
                    },
                    {
                        "drugbank-id": "DB11633",
                        "description": "The serum concentration of Brentuximab vedotin can be increased when it is combined with Isavuconazole"
                    },
                    {
                        "drugbank-id": "DB11753",
                        "description": "The serum concentration of Brentuximab vedotin can be increased when it is combined with Rifamycin"
                    },
                    {
                        "drugbank-id": "DB11828",
                        "description": "The serum concentration of Brentuximab vedotin can be increased when it is combined with Neratinib"
                    },
                    {
                        "drugbank-id": "DB11869",
                        "description": "The serum concentration of Brentuximab vedotin can be increased when it is combined with Valspodar"
                    },
                    {
                        "drugbank-id": "DB11963",
                        "description": "The serum concentration of Brentuximab vedotin can be increased when it is combined with Dacomitinib"
                    },
                    {
                        "drugbank-id": "DB11978",
                        "description": "The serum concentration of Brentuximab vedotin can be increased when it is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB12026",
                        "description": "The serum concentration of Brentuximab vedotin can be increased when it is combined with Voxilaprevir"
                    },
                    {
                        "drugbank-id": "DB12035",
                        "description": "The serum concentration of Brentuximab vedotin can be increased when it is combined with Sarecycline"
                    },
                    {
                        "drugbank-id": "DB12332",
                        "description": "The serum concentration of Brentuximab vedotin can be increased when it is combined with Rucaparib"
                    },
                    {
                        "drugbank-id": "DB12799",
                        "description": "The serum concentration of Brentuximab vedotin can be increased when it is combined with Laniquidar"
                    },
                    {
                        "drugbank-id": "DB13874",
                        "description": "The serum concentration of Brentuximab vedotin can be increased when it is combined with Enasidenib"
                    },
                    {
                        "drugbank-id": "DB13878",
                        "description": "The serum concentration of Brentuximab vedotin can be increased when it is combined with Pibrentasvir"
                    },
                    {
                        "drugbank-id": "DB13879",
                        "description": "The serum concentration of Brentuximab vedotin can be increased when it is combined with Glecaprevir"
                    },
                    {
                        "drugbank-id": "DB14068",
                        "description": "The serum concentration of Brentuximab vedotin can be increased when it is combined with Dexniguldipine"
                    },
                    {
                        "drugbank-id": "DB14069",
                        "description": "The serum concentration of Brentuximab vedotin can be increased when it is combined with ONT 093"
                    },
                    {
                        "drugbank-id": "DB14568",
                        "description": "The serum concentration of Brentuximab vedotin can be increased when it is combined with Ivosidenib"
                    },
                    {
                        "drugbank-id": "DB11986",
                        "description": "The serum concentration of Entrectinib can be increased when it is combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB12500",
                        "description": "The serum concentration of Brentuximab vedotin can be increased when it is combined with Fedratinib"
                    },
                    {
                        "drugbank-id": "DB11757",
                        "description": "The serum concentration of Brentuximab vedotin can be increased when it is combined with Istradefylline"
                    },
                    {
                        "drugbank-id": "DB11732",
                        "description": "The serum concentration of Brentuximab vedotin can be increased when it is combined with Lasmiditan"
                    },
                    {
                        "drugbank-id": "DB00957",
                        "description": "The serum concentration of Brentuximab vedotin can be increased when it is combined with Norgestimate"
                    },
                    {
                        "drugbank-id": "DB11979",
                        "description": "The serum concentration of Brentuximab vedotin can be increased when it is combined with Elagolix"
                    },
                    {
                        "drugbank-id": "DB12466",
                        "description": "The serum concentration of Brentuximab vedotin can be increased when it is combined with Favipiravir"
                    },
                    {
                        "drugbank-id": "DB09241",
                        "description": "The serum concentration of Brentuximab vedotin can be increased when it is combined with Methylene blue"
                    },
                    {
                        "drugbank-id": "DB00845",
                        "description": "The serum concentration of Brentuximab vedotin can be increased when it is combined with Clofazimine"
                    },
                    {
                        "drugbank-id": "DB14840",
                        "description": "The serum concentration of Brentuximab vedotin can be increased when it is combined with Ripretinib"
                    },
                    {
                        "drugbank-id": "DB15822",
                        "description": "The serum concentration of Brentuximab vedotin can be increased when it is combined with Pralsetinib"
                    },
                    {
                        "drugbank-id": "DB06448",
                        "description": "The serum concentration of Brentuximab vedotin can be increased when it is combined with Lonafarnib"
                    },
                    {
                        "drugbank-id": "DB09039",
                        "description": "The metabolism of Eliglustat can be decreased when combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB09053",
                        "description": "The metabolism of Ibrutinib can be decreased when combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB01166",
                        "description": "The metabolism of Cilostazol can be decreased when combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB01394",
                        "description": "The metabolism of Colchicine can be decreased when combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB00813",
                        "description": "The metabolism of Fentanyl can be decreased when combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB04946",
                        "description": "The metabolism of Iloperidone can be decreased when combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB01256",
                        "description": "The metabolism of Retapamulin can be decreased when combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB08895",
                        "description": "The metabolism of Tofacitinib can be decreased when combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB00862",
                        "description": "The metabolism of Vardenafil can be decreased when combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB00402",
                        "description": "The metabolism of Eszopiclone can be decreased when combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB01198",
                        "description": "The metabolism of Zopiclone can be decreased when combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB00227",
                        "description": "The metabolism of Lovastatin can be decreased when combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB00451",
                        "description": "The serum concentration of Brentuximab vedotin can be decreased when it is combined with Levothyroxine"
                    },
                    {
                        "drugbank-id": "DB00656",
                        "description": "The serum concentration of Brentuximab vedotin can be decreased when it is combined with Trazodone"
                    },
                    {
                        "drugbank-id": "DB01323",
                        "description": "The serum concentration of Brentuximab vedotin can be decreased when it is combined with St John s Wort"
                    },
                    {
                        "drugbank-id": "DB06414",
                        "description": "The serum concentration of Brentuximab vedotin can be decreased when it is combined with Etravirine"
                    },
                    {
                        "drugbank-id": "DB11901",
                        "description": "The serum concentration of Brentuximab vedotin can be decreased when it is combined with Apalutamide"
                    },
                    {
                        "drugbank-id": "DB01045",
                        "description": "The serum concentration of Brentuximab vedotin can be decreased when it is combined with Rifampicin"
                    },
                    {
                        "drugbank-id": "DB14631",
                        "description": "The serum concentration of Brentuximab vedotin can be decreased when it is combined with Prednisolone phosphate"
                    },
                    {
                        "drugbank-id": "DB00290",
                        "description": "The risk or severity of pulmonary toxicity can be increased when Brentuximab vedotin is combined with Bleomycin"
                    },
                    {
                        "drugbank-id": "DB09046",
                        "description": "The metabolism of Brentuximab vedotin can be increased when combined with Metreleptin"
                    },
                    {
                        "drugbank-id": "DB00346",
                        "description": "The metabolism of Alfuzosin can be decreased when combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB00404",
                        "description": "The metabolism of Alprazolam can be decreased when combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB00682",
                        "description": "The serum concentration of Warfarin can be increased when it is combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB01418",
                        "description": "The serum concentration of Acenocoumarol can be increased when it is combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB08496",
                        "description": "The serum concentration of R warfarin can be increased when it is combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB08735",
                        "description": "The serum concentration of R S Warfarin alcohol can be increased when it is combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB08736",
                        "description": "The serum concentration of S R Warfarin alcohol can be increased when it is combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB14055",
                        "description": "The serum concentration of S Warfarin can be increased when it is combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB00683",
                        "description": "The serum concentration of Midazolam can be increased when it is combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB00864",
                        "description": "The serum concentration of Tacrolimus can be increased when it is combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB08865",
                        "description": "The metabolism of Brentuximab vedotin can be decreased when combined with Crizotinib"
                    },
                    {
                        "drugbank-id": "DB01015",
                        "description": "The risk or severity of myelosuppression can be increased when Sulfamethoxazole is combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB01076",
                        "description": "The metabolism of Atorvastatin can be decreased when combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB00269",
                        "description": "Chlorotrianisene may increase the thrombogenic activities of Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB00655",
                        "description": "Estrone may increase the thrombogenic activities of Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB00890",
                        "description": "Dienestrol may increase the thrombogenic activities of Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB04575",
                        "description": "Quinestrol may increase the thrombogenic activities of Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB07931",
                        "description": "Hexestrol may increase the thrombogenic activities of Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB09070",
                        "description": "Tibolone may increase the thrombogenic activities of Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB09369",
                        "description": "Polyestradiol phosphate may increase the thrombogenic activities of Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB11478",
                        "description": "Zeranol may increase the thrombogenic activities of Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB11674",
                        "description": "Equol may increase the thrombogenic activities of Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB12487",
                        "description": "Promestriene may increase the thrombogenic activities of Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB13143",
                        "description": "Methallenestril may increase the thrombogenic activities of Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB13386",
                        "description": "Epimestrol may increase the thrombogenic activities of Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB13418",
                        "description": "Moxestrol may increase the thrombogenic activities of Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB15334",
                        "description": "Biochanin A may increase the thrombogenic activities of Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB15335",
                        "description": "Formononetin may increase the thrombogenic activities of Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB00286",
                        "description": "Conjugated estrogens may increase the thrombogenic activities of Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB00783",
                        "description": "Estradiol may increase the thrombogenic activities of Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB00977",
                        "description": "Ethinylestradiol may increase the thrombogenic activities of Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB01357",
                        "description": "Mestranol may increase the thrombogenic activities of Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB04574",
                        "description": "Estrone sulfate may increase the thrombogenic activities of Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB09317",
                        "description": "Synthetic Conjugated Estrogens A may increase the thrombogenic activities of Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB09318",
                        "description": "Synthetic Conjugated Estrogens B may increase the thrombogenic activities of Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB09381",
                        "description": "Esterified estrogens may increase the thrombogenic activities of Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB04573",
                        "description": "Estriol may increase the thrombogenic activities of Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB01097",
                        "description": "The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Leflunomide"
                    },
                    {
                        "drugbank-id": "DB00072",
                        "description": "Trastuzumab may increase the neutropenic activities of Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB08868",
                        "description": "Brentuximab vedotin may increase the immunosuppressive activities of Fingolimod"
                    },
                    {
                        "drugbank-id": "DB04914",
                        "description": "The therapeutic efficacy of G17DT can be decreased when used in combination with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB05144",
                        "description": "The therapeutic efficacy of PEV3A can be decreased when used in combination with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB05325",
                        "description": "The therapeutic efficacy of INGN 225 can be decreased when used in combination with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB05374",
                        "description": "The therapeutic efficacy of Rindopepimut can be decreased when used in combination with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB05440",
                        "description": "The therapeutic efficacy of SRP 299 can be decreased when used in combination with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB05942",
                        "description": "The therapeutic efficacy of GI 5005 can be decreased when used in combination with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB06400",
                        "description": "The therapeutic efficacy of Vitespen can be decreased when used in combination with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB06584",
                        "description": "The therapeutic efficacy of TG4010 can be decreased when used in combination with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB09057",
                        "description": "The therapeutic efficacy of Anthrax immune globulin human can be decreased when used in combination with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB10062",
                        "description": "The therapeutic efficacy of Rabies virus inactivated antigen B can be decreased when used in combination with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB10076",
                        "description": "The therapeutic efficacy of Haemophilus influenzae type B strain 1482 capsular polysaccharide tetanus toxoid conjugate antigen can be decreased when used in combination with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB10276",
                        "description": "The therapeutic efficacy of Rotavirus vaccine can be decreased when used in combination with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB10283",
                        "description": "The therapeutic efficacy of Rabies virus inactivated antigen A can be decreased when used in combination with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB10342",
                        "description": "The therapeutic efficacy of Haemophilus influenzae type B capsular polysaccharide meningococcal outer membrane protein conjugate antigen can be decreased when used in combination with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB10583",
                        "description": "The therapeutic efficacy of Clostridium tetani toxoid antigen formaldehyde inactivated can be decreased when used in combination with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB10584",
                        "description": "The therapeutic efficacy of Corynebacterium diphtheriae toxoid antigen formaldehyde inactivated can be decreased when used in combination with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB10600",
                        "description": "The therapeutic efficacy of Influenza A virus A California 7 2009 X 181 H1N1 antigen propiolactone inactivated can be decreased when used in combination with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB10769",
                        "description": "The therapeutic efficacy of Japanese encephalitis virus strain sa 14 14 2 antigen formaldehyde inactivated can be decreased when used in combination with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB10794",
                        "description": "The therapeutic efficacy of Influenza B virus B Brisbane 60 2008 antigen formaldehyde inactivated can be decreased when used in combination with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB10803",
                        "description": "The therapeutic efficacy of Typhoid Vi polysaccharide vaccine can be decreased when used in combination with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB10989",
                        "description": "The therapeutic efficacy of Hepatitis A Vaccine can be decreased when used in combination with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB10990",
                        "description": "The therapeutic efficacy of Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen can be decreased when used in combination with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB11038",
                        "description": "The therapeutic efficacy of Influenza A virus A Brisbane 59 2007 H1N1 hemagglutinin antigen propiolactone inactivated can be decreased when used in combination with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB11040",
                        "description": "The therapeutic efficacy of Influenza B virus B Brisbane 60 2008 hemagglutinin antigen propiolactone inactivated can be decreased when used in combination with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB11041",
                        "description": "The therapeutic efficacy of Influenza A virus A California 7 2009 X 181 H1N1 hemagglutinin antigen propiolactone inactivated can be decreased when used in combination with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB11044",
                        "description": "The therapeutic efficacy of Influenza B virus B Brisbane 60 2008 antigen propiolactone inactivated can be decreased when used in combination with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB11603",
                        "description": "The therapeutic efficacy of Human rabies virus immune globulin can be decreased when used in combination with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB11627",
                        "description": "The therapeutic efficacy of Hepatitis B Vaccine Recombinant can be decreased when used in combination with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB12568",
                        "description": "The therapeutic efficacy of Tecemotide can be decreased when used in combination with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB14022",
                        "description": "The therapeutic efficacy of Typhoid vaccine can be decreased when used in combination with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB14384",
                        "description": "The therapeutic efficacy of Influenza A virus A Victoria 210 2009 X 187 H3N2 hemagglutinin antigen formaldehyde inactivated can be decreased when used in combination with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB14385",
                        "description": "The therapeutic efficacy of Influenza B virus B Brisbane 60 2008 hemagglutinin antigen formaldehyde inactivated can be decreased when used in combination with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB14394",
                        "description": "The therapeutic efficacy of Influenza A virus A California 7 2009 H1N1 live attenuated antigen can be decreased when used in combination with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB14445",
                        "description": "The therapeutic efficacy of Influenza A virus A Victoria 210 2009 X 187 H3N2 antigen formaldehyde inactivated can be decreased when used in combination with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB14449",
                        "description": "The therapeutic efficacy of Influenza A virus A Perth 16 2009 H3N2 live attenuated antigen can be decreased when used in combination with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB14619",
                        "description": "The therapeutic efficacy of Influenza A virus A Uruguay 716 2007 H3N2 antigen propiolactone inactivated can be decreased when used in combination with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB14620",
                        "description": "The therapeutic efficacy of Influenza A virus A Brisbane 59 2007 H1N1 antigen propiolactone inactivated can be decreased when used in combination with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB14711",
                        "description": "The therapeutic efficacy of Smallpox Vaccinia Vaccine Live can be decreased when used in combination with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB15274",
                        "description": "The therapeutic efficacy of Pertussis vaccine can be decreased when used in combination with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB15461",
                        "description": "The therapeutic efficacy of Yersinia pestis 195 p antigen formaldehyde inactivated can be decreased when used in combination with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB13924",
                        "description": "The therapeutic efficacy of Varicella Zoster Vaccine Recombinant can be decreased when used in combination with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB15483",
                        "description": "The therapeutic efficacy of Modified vaccinia ankara can be decreased when used in combination with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB15654",
                        "description": "The therapeutic efficacy of Moderna COVID 19 Vaccine can be decreased when used in combination with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB11988",
                        "description": "Ocrelizumab may increase the immunosuppressive activities of Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB11642",
                        "description": "The serum concentration of Brentuximab vedotin can be decreased when it is combined with Pitolisant"
                    },
                    {
                        "drugbank-id": "DB10317",
                        "description": "The risk or severity of infection can be increased when Rubella virus vaccine is combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB10318",
                        "description": "The risk or severity of infection can be increased when Varicella Zoster Vaccine Live attenuated is combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB10343",
                        "description": "The risk or severity of infection can be increased when Bacillus calmette guerin substrain tice live antigen is combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB10804",
                        "description": "The risk or severity of infection can be increased when Bacillus calmette guerin substrain connaught live antigen is combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB10805",
                        "description": "The risk or severity of infection can be increased when Yellow Fever Vaccine is combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB11003",
                        "description": "The risk or severity of infection can be increased when Anthrax vaccine is combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB11050",
                        "description": "The risk or severity of infection can be increased when Typhoid Vaccine Live is combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB12386",
                        "description": "The risk or severity of infection can be increased when Bacillus calmette guerin substrain danish 1331 live antigen is combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB12768",
                        "description": "The risk or severity of infection can be increased when BCG vaccine is combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB14409",
                        "description": "The risk or severity of infection can be increased when Human adenovirus e serotype 4 strain cl 68578 antigen is combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB14443",
                        "description": "The risk or severity of infection can be increased when Vibrio cholerae CVD 103 HgR strain live antigen is combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB14685",
                        "description": "The risk or severity of infection can be increased when Adenovirus type 7 vaccine live is combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB00002",
                        "description": "The risk or severity of adverse effects can be increased when Cetuximab is combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB00028",
                        "description": "The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB00043",
                        "description": "The risk or severity of adverse effects can be increased when Omalizumab is combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB00054",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB00057",
                        "description": "The risk or severity of adverse effects can be increased when Indium In 111 satumomab pendetide is combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB00076",
                        "description": "The risk or severity of adverse effects can be increased when Digoxin Immune Fab Ovine is combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB00089",
                        "description": "The risk or severity of adverse effects can be increased when Capromab pendetide is combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB00110",
                        "description": "The risk or severity of adverse effects can be increased when Palivizumab is combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB00113",
                        "description": "The risk or severity of adverse effects can be increased when Technetium Tc 99m arcitumomab is combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB01269",
                        "description": "The risk or severity of adverse effects can be increased when Panitumumab is combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB01270",
                        "description": "The risk or severity of adverse effects can be increased when Ranibizumab is combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB04901",
                        "description": "The risk or severity of adverse effects can be increased when Galiximab is combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB04949",
                        "description": "The risk or severity of adverse effects can be increased when Pexelizumab is combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB04958",
                        "description": "The risk or severity of adverse effects can be increased when Epratuzumab is combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB04962",
                        "description": "The risk or severity of adverse effects can be increased when Bectumomab is combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB04964",
                        "description": "The risk or severity of adverse effects can be increased when Oregovomab is combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB04988",
                        "description": "The risk or severity of adverse effects can be increased when IGN311 is combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB05006",
                        "description": "The risk or severity of adverse effects can be increased when Adecatumumab is combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB05097",
                        "description": "The risk or severity of adverse effects can be increased when Labetuzumab is combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB05101",
                        "description": "The risk or severity of adverse effects can be increased when Matuzumab is combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB05111",
                        "description": "The risk or severity of adverse effects can be increased when Fontolizumab is combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB05136",
                        "description": "The risk or severity of adverse effects can be increased when Bavituximab is combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB05139",
                        "description": "The risk or severity of adverse effects can be increased when CR002 is combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB05209",
                        "description": "The risk or severity of adverse effects can be increased when Rozrolimupab is combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB05304",
                        "description": "The risk or severity of adverse effects can be increased when Girentuximab is combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB05336",
                        "description": "The risk or severity of adverse effects can be increased when Obiltoxaximab is combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB05405",
                        "description": "The risk or severity of adverse effects can be increased when XTL 001 is combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB05437",
                        "description": "The risk or severity of adverse effects can be increased when NAV 1800 is combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB05496",
                        "description": "The risk or severity of adverse effects can be increased when Otelixizumab is combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB05545",
                        "description": "The risk or severity of adverse effects can be increased when AMG 108 is combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB05550",
                        "description": "The risk or severity of adverse effects can be increased when Iratumumab is combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB05555",
                        "description": "The risk or severity of adverse effects can be increased when Enokizumab is combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB05578",
                        "description": "The risk or severity of adverse effects can be increased when Ramucirumab is combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB05595",
                        "description": "The risk or severity of adverse effects can be increased when Farletuzumab is combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB05656",
                        "description": "The risk or severity of adverse effects can be increased when Veltuzumab is combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB05793",
                        "description": "The risk or severity of adverse effects can be increased when PRO 542 is combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB05797",
                        "description": "The risk or severity of adverse effects can be increased when TNX 901 is combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB05892",
                        "description": "The risk or severity of adverse effects can be increased when RI 624 is combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB05915",
                        "description": "The risk or severity of adverse effects can be increased when MYO 029 is combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB05916",
                        "description": "The risk or severity of adverse effects can be increased when CT 011 is combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB05941",
                        "description": "The risk or severity of adverse effects can be increased when Leronlimab is combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB05996",
                        "description": "The risk or severity of adverse effects can be increased when Glembatumumab vedotin is combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB06043",
                        "description": "The risk or severity of adverse effects can be increased when Olaratumab is combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB06049",
                        "description": "The risk or severity of adverse effects can be increased when IPH 2101 is combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB06050",
                        "description": "The risk or severity of adverse effects can be increased when TB 402 is combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB06081",
                        "description": "The risk or severity of adverse effects can be increased when Caplacizumab is combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB06101",
                        "description": "The risk or severity of adverse effects can be increased when IMC 1C11 is combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB06116",
                        "description": "The risk or severity of adverse effects can be increased when Eldelumab is combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB06162",
                        "description": "The risk or severity of adverse effects can be increased when Lumiliximab is combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB06186",
                        "description": "The risk or severity of adverse effects can be increased when Ipilimumab is combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB06192",
                        "description": "The risk or severity of adverse effects can be increased when Nimotuzumab is combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB06241",
                        "description": "The risk or severity of adverse effects can be increased when Clenoliximab is combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB06304",
                        "description": "The risk or severity of adverse effects can be increased when BIIB015 is combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB06305",
                        "description": "The risk or severity of adverse effects can be increased when Sonepcizumab is combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB06310",
                        "description": "The risk or severity of adverse effects can be increased when Motavizumab is combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB06317",
                        "description": "The risk or severity of adverse effects can be increased when Elotuzumab is combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB06322",
                        "description": "The risk or severity of adverse effects can be increased when Carotuximab is combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB06324",
                        "description": "The risk or severity of adverse effects can be increased when XmAb 2513 is combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB06343",
                        "description": "The risk or severity of adverse effects can be increased when Teprotumumab is combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB06360",
                        "description": "The risk or severity of adverse effects can be increased when Lucatumumab is combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB06366",
                        "description": "The risk or severity of adverse effects can be increased when Pertuzumab is combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB06371",
                        "description": "The risk or severity of adverse effects can be increased when Siplizumab is combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB06467",
                        "description": "The risk or severity of adverse effects can be increased when Apolizumab is combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB06474",
                        "description": "The risk or severity of adverse effects can be increased when Sibrotuzumab is combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB06550",
                        "description": "The risk or severity of adverse effects can be increased when Bivatuzumab is combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB06557",
                        "description": "The risk or severity of adverse effects can be increased when Lerdelimumab is combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB06599",
                        "description": "The risk or severity of adverse effects can be increased when Lexatumumab is combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB06602",
                        "description": "The risk or severity of adverse effects can be increased when Reslizumab is combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB06606",
                        "description": "The risk or severity of adverse effects can be increased when Teplizumab is combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB06607",
                        "description": "The risk or severity of adverse effects can be increased when Catumaxomab is combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB06647",
                        "description": "The risk or severity of adverse effects can be increased when Volociximab is combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB06650",
                        "description": "The risk or severity of adverse effects can be increased when Ofatumumab is combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB08902",
                        "description": "The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Raxibacumab"
                    },
                    {
                        "drugbank-id": "DB09035",
                        "description": "The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Nivolumab"
                    },
                    {
                        "drugbank-id": "DB09037",
                        "description": "The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Pembrolizumab"
                    },
                    {
                        "drugbank-id": "DB09045",
                        "description": "The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Dulaglutide"
                    },
                    {
                        "drugbank-id": "DB09105",
                        "description": "The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Asfotase alfa"
                    },
                    {
                        "drugbank-id": "DB09264",
                        "description": "The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Idarucizumab"
                    },
                    {
                        "drugbank-id": "DB09302",
                        "description": "The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Alirocumab"
                    },
                    {
                        "drugbank-id": "DB09303",
                        "description": "The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Evolocumab"
                    },
                    {
                        "drugbank-id": "DB09331",
                        "description": "The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Daratumumab"
                    },
                    {
                        "drugbank-id": "DB09559",
                        "description": "The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Necitumumab"
                    },
                    {
                        "drugbank-id": "DB11595",
                        "description": "The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Atezolizumab"
                    },
                    {
                        "drugbank-id": "DB11604",
                        "description": "The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Tetanus Immune Globulin"
                    },
                    {
                        "drugbank-id": "DB11608",
                        "description": "The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Eftrenonacog alfa"
                    },
                    {
                        "drugbank-id": "DB11621",
                        "description": "The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Human Varicella Zoster Immune Globulin"
                    },
                    {
                        "drugbank-id": "DB11646",
                        "description": "The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Conatumumab"
                    },
                    {
                        "drugbank-id": "DB11657",
                        "description": "The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Tabalumab"
                    },
                    {
                        "drugbank-id": "DB11680",
                        "description": "The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Ficlatuzumab"
                    },
                    {
                        "drugbank-id": "DB11685",
                        "description": "The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Figitumumab"
                    },
                    {
                        "drugbank-id": "DB11714",
                        "description": "The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Durvalumab"
                    },
                    {
                        "drugbank-id": "DB11715",
                        "description": "The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Bapineuzumab"
                    },
                    {
                        "drugbank-id": "DB11731",
                        "description": "The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Depatuxizumab mafodotin"
                    },
                    {
                        "drugbank-id": "DB11746",
                        "description": "The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Onartuzumab"
                    },
                    {
                        "drugbank-id": "DB11756",
                        "description": "The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Solanezumab"
                    },
                    {
                        "drugbank-id": "DB11771",
                        "description": "The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Tremelimumab"
                    },
                    {
                        "drugbank-id": "DB11826",
                        "description": "The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Lampalizumab"
                    },
                    {
                        "drugbank-id": "DB11840",
                        "description": "The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Dalotuzumab"
                    },
                    {
                        "drugbank-id": "DB11849",
                        "description": "The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Emibetuzumab"
                    },
                    {
                        "drugbank-id": "DB11850",
                        "description": "The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Ublituximab"
                    },
                    {
                        "drugbank-id": "DB11856",
                        "description": "The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Ligelizumab"
                    },
                    {
                        "drugbank-id": "DB11857",
                        "description": "The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Seribantumab"
                    },
                    {
                        "drugbank-id": "DB11862",
                        "description": "The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Landogrozumab"
                    },
                    {
                        "drugbank-id": "DB11866",
                        "description": "The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Romosozumab"
                    },
                    {
                        "drugbank-id": "DB11884",
                        "description": "The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Vadastuximab Talirine"
                    },
                    {
                        "drugbank-id": "DB11914",
                        "description": "The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Lebrikizumab"
                    },
                    {
                        "drugbank-id": "DB11930",
                        "description": "The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Varlilumab"
                    },
                    {
                        "drugbank-id": "DB11945",
                        "description": "The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Avelumab"
                    },
                    {
                        "drugbank-id": "DB11959",
                        "description": "The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Crenezumab"
                    },
                    {
                        "drugbank-id": "DB11972",
                        "description": "The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Rilotumumab"
                    },
                    {
                        "drugbank-id": "DB11976",
                        "description": "The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Anifrolumab"
                    },
                    {
                        "drugbank-id": "DB12023",
                        "description": "The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Benralizumab"
                    },
                    {
                        "drugbank-id": "DB12034",
                        "description": "The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Gantenerumab"
                    },
                    {
                        "drugbank-id": "DB12053",
                        "description": "The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Visilizumab"
                    },
                    {
                        "drugbank-id": "DB12077",
                        "description": "The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Urelumab"
                    },
                    {
                        "drugbank-id": "DB12090",
                        "description": "The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Patritumab"
                    },
                    {
                        "drugbank-id": "DB12102",
                        "description": "The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Fulranumab"
                    },
                    {
                        "drugbank-id": "DB12104",
                        "description": "The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Tarextumab"
                    },
                    {
                        "drugbank-id": "DB12118",
                        "description": "The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Sotatercept"
                    },
                    {
                        "drugbank-id": "DB12119",
                        "description": "The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Gevokizumab"
                    },
                    {
                        "drugbank-id": "DB12142",
                        "description": "The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Duligotuzumab"
                    },
                    {
                        "drugbank-id": "DB12152",
                        "description": "The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Simtuzumab"
                    },
                    {
                        "drugbank-id": "DB12157",
                        "description": "The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Fasinumab"
                    },
                    {
                        "drugbank-id": "DB12159",
                        "description": "The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Dupilumab"
                    },
                    {
                        "drugbank-id": "DB12169",
                        "description": "The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Tralokinumab"
                    },
                    {
                        "drugbank-id": "DB12189",
                        "description": "The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Etrolizumab"
                    },
                    {
                        "drugbank-id": "DB12202",
                        "description": "The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Zalutumumab"
                    },
                    {
                        "drugbank-id": "DB12205",
                        "description": "The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Ganitumab"
                    },
                    {
                        "drugbank-id": "DB12213",
                        "description": "The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Etaracizumab"
                    },
                    {
                        "drugbank-id": "DB12246",
                        "description": "The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Inclacumab"
                    },
                    {
                        "drugbank-id": "DB12250",
                        "description": "The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Cixutumumab"
                    },
                    {
                        "drugbank-id": "DB12261",
                        "description": "The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Ascrinvacumab"
                    },
                    {
                        "drugbank-id": "DB12274",
                        "description": "The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Aducanumab"
                    },
                    {
                        "drugbank-id": "DB12281",
                        "description": "The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Luspatercept"
                    },
                    {
                        "drugbank-id": "DB12296",
                        "description": "The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with GS 5745"
                    },
                    {
                        "drugbank-id": "DB12317",
                        "description": "The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Vanucizumab"
                    },
                    {
                        "drugbank-id": "DB12331",
                        "description": "The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Labetuzumab govitecan"
                    },
                    {
                        "drugbank-id": "DB12335",
                        "description": "The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Tanezumab"
                    },
                    {
                        "drugbank-id": "DB12342",
                        "description": "The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Ensituximab"
                    },
                    {
                        "drugbank-id": "DB12344",
                        "description": "The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Fezakinumab"
                    },
                    {
                        "drugbank-id": "DB12363",
                        "description": "The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Dusigitumab"
                    },
                    {
                        "drugbank-id": "DB12396",
                        "description": "The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Fresolimumab"
                    },
                    {
                        "drugbank-id": "DB12413",
                        "description": "The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Indusatumab vedotin"
                    },
                    {
                        "drugbank-id": "DB12456",
                        "description": "The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Bococizumab"
                    },
                    {
                        "drugbank-id": "DB12498",
                        "description": "The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Mogamulizumab"
                    },
                    {
                        "drugbank-id": "DB12520",
                        "description": "The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Plozalizumab"
                    },
                    {
                        "drugbank-id": "DB12534",
                        "description": "The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Mavrilimumab"
                    },
                    {
                        "drugbank-id": "DB12560",
                        "description": "The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Blosozumab"
                    },
                    {
                        "drugbank-id": "DB12584",
                        "description": "The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Bimagrumab"
                    },
                    {
                        "drugbank-id": "DB12589",
                        "description": "The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Dacetuzumab"
                    },
                    {
                        "drugbank-id": "DB12609",
                        "description": "The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Tovetumab"
                    },
                    {
                        "drugbank-id": "DB12683",
                        "description": "The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Lumretuzumab"
                    },
                    {
                        "drugbank-id": "DB12698",
                        "description": "The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Ibalizumab"
                    },
                    {
                        "drugbank-id": "DB12701",
                        "description": "The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Intetumumab"
                    },
                    {
                        "drugbank-id": "DB12718",
                        "description": "The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Carlumab"
                    },
                    {
                        "drugbank-id": "DB12734",
                        "description": "The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Demcizumab"
                    },
                    {
                        "drugbank-id": "DB12773",
                        "description": "The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Sifalimumab"
                    },
                    {
                        "drugbank-id": "DB12775",
                        "description": "The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Abituzumab"
                    },
                    {
                        "drugbank-id": "DB12797",
                        "description": "The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Ecromeximab"
                    },
                    {
                        "drugbank-id": "DB12807",
                        "description": "The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Naptumomab Estafenatox"
                    },
                    {
                        "drugbank-id": "DB12815",
                        "description": "The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Crotedumab"
                    },
                    {
                        "drugbank-id": "DB12820",
                        "description": "The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Concizumab"
                    },
                    {
                        "drugbank-id": "DB12826",
                        "description": "The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Depatuxizumab"
                    },
                    {
                        "drugbank-id": "DB12844",
                        "description": "The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Rontalizumab"
                    },
                    {
                        "drugbank-id": "DB12845",
                        "description": "The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Amatuximab"
                    },
                    {
                        "drugbank-id": "DB12849",
                        "description": "The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Clazakizumab"
                    },
                    {
                        "drugbank-id": "DB12891",
                        "description": "The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Ozanezumab"
                    },
                    {
                        "drugbank-id": "DB12893",
                        "description": "The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Sacituzumab govitecan"
                    },
                    {
                        "drugbank-id": "DB12917",
                        "description": "The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Bimekizumab"
                    },
                    {
                        "drugbank-id": "DB12943",
                        "description": "The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Milatuzumab"
                    },
                    {
                        "drugbank-id": "DB12976",
                        "description": "The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Robatumumab"
                    },
                    {
                        "drugbank-id": "DB13017",
                        "description": "The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Rovalpituzumab Tesirine"
                    },
                    {
                        "drugbank-id": "DB13037",
                        "description": "The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Namilumab"
                    },
                    {
                        "drugbank-id": "DB13045",
                        "description": "The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Racotumomab"
                    },
                    {
                        "drugbank-id": "DB13073",
                        "description": "The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Tregalizumab"
                    },
                    {
                        "drugbank-id": "DB13127",
                        "description": "The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Olokizumab"
                    },
                    {
                        "drugbank-id": "DB13140",
                        "description": "The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Bezlotoxumab"
                    },
                    {
                        "drugbank-id": "DB13375",
                        "description": "The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Edrecolomab"
                    },
                    {
                        "drugbank-id": "DB13535",
                        "description": "The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Nebacumab"
                    },
                    {
                        "drugbank-id": "DB13886",
                        "description": "The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Human cytomegalovirus immune globulin"
                    },
                    {
                        "drugbank-id": "DB13923",
                        "description": "The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Emicizumab"
                    },
                    {
                        "drugbank-id": "DB13976",
                        "description": "The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Sulesomab"
                    },
                    {
                        "drugbank-id": "DB13979",
                        "description": "The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Besilesomab"
                    },
                    {
                        "drugbank-id": "DB14012",
                        "description": "The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Burosumab"
                    },
                    {
                        "drugbank-id": "DB14039",
                        "description": "The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Erenumab"
                    },
                    {
                        "drugbank-id": "DB14040",
                        "description": "The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Eptinezumab"
                    },
                    {
                        "drugbank-id": "DB14041",
                        "description": "The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Fremanezumab"
                    },
                    {
                        "drugbank-id": "DB14042",
                        "description": "The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Galcanezumab"
                    },
                    {
                        "drugbank-id": "DB14211",
                        "description": "The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Fanolesomab"
                    },
                    {
                        "drugbank-id": "DB14580",
                        "description": "The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Lecanemab"
                    },
                    {
                        "drugbank-id": "DB14597",
                        "description": "The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Lanadelumab"
                    },
                    {
                        "drugbank-id": "DB14707",
                        "description": "The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Cemiplimab"
                    },
                    {
                        "drugbank-id": "DB14776",
                        "description": "The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Camrelizumab"
                    },
                    {
                        "drugbank-id": "DB14778",
                        "description": "The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Setrusumab"
                    },
                    {
                        "drugbank-id": "DB14784",
                        "description": "The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Gancotamab"
                    },
                    {
                        "drugbank-id": "DB14809",
                        "description": "The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Anetumab ravtansine"
                    },
                    {
                        "drugbank-id": "DB14811",
                        "description": "The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Isatuximab"
                    },
                    {
                        "drugbank-id": "DB14824",
                        "description": "The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Icrucumab"
                    },
                    {
                        "drugbank-id": "DB14843",
                        "description": "The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Codrituzumab"
                    },
                    {
                        "drugbank-id": "DB14864",
                        "description": "The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Brolucizumab"
                    },
                    {
                        "drugbank-id": "DB14871",
                        "description": "The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Xentuzumab"
                    },
                    {
                        "drugbank-id": "DB14877",
                        "description": "The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Lintuzumab"
                    },
                    {
                        "drugbank-id": "DB14891",
                        "description": "The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Vobarilizumab"
                    },
                    {
                        "drugbank-id": "DB14897",
                        "description": "The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Parsatuzumab"
                    },
                    {
                        "drugbank-id": "DB14905",
                        "description": "The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Emactuzumab"
                    },
                    {
                        "drugbank-id": "DB14907",
                        "description": "The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Bevacizumab zirconium Zr 89"
                    },
                    {
                        "drugbank-id": "DB14908",
                        "description": "The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Refanezumab"
                    },
                    {
                        "drugbank-id": "DB14947",
                        "description": "The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Bermekimab"
                    },
                    {
                        "drugbank-id": "DB14952",
                        "description": "The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Pamrevlumab"
                    },
                    {
                        "drugbank-id": "DB14959",
                        "description": "The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Opicinumab"
                    },
                    {
                        "drugbank-id": "DB14962",
                        "description": "The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Trastuzumab deruxtecan"
                    },
                    {
                        "drugbank-id": "DB14967",
                        "description": "The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Margetuximab"
                    },
                    {
                        "drugbank-id": "DB14988",
                        "description": "The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Dalantercept"
                    },
                    {
                        "drugbank-id": "DB14997",
                        "description": "The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Pateclizumab"
                    },
                    {
                        "drugbank-id": "DB15014",
                        "description": "The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Gremubamab"
                    },
                    {
                        "drugbank-id": "DB15022",
                        "description": "The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Apomab"
                    },
                    {
                        "drugbank-id": "DB15044",
                        "description": "The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Tafasitamab"
                    },
                    {
                        "drugbank-id": "DB15045",
                        "description": "The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Ipafricept"
                    },
                    {
                        "drugbank-id": "DB15076",
                        "description": "The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Abrilumab"
                    },
                    {
                        "drugbank-id": "DB15089",
                        "description": "The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Frovocimab"
                    },
                    {
                        "drugbank-id": "DB15090",
                        "description": "The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Tezepelumab"
                    },
                    {
                        "drugbank-id": "DB15101",
                        "description": "The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Tigatuzumab"
                    },
                    {
                        "drugbank-id": "DB15104",
                        "description": "The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Telisotuzumab vedotin"
                    },
                    {
                        "drugbank-id": "DB15113",
                        "description": "The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Utomilumab"
                    },
                    {
                        "drugbank-id": "DB15118",
                        "description": "The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Zolbetuximab"
                    },
                    {
                        "drugbank-id": "DB15135",
                        "description": "The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Ponezumab"
                    },
                    {
                        "drugbank-id": "DB15160",
                        "description": "The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Asunercept"
                    },
                    {
                        "drugbank-id": "DB15172",
                        "description": "The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Suvratoxumab"
                    },
                    {
                        "drugbank-id": "DB15225",
                        "description": "The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Mitazalimab"
                    },
                    {
                        "drugbank-id": "DB15252",
                        "description": "The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Nemolizumab"
                    },
                    {
                        "drugbank-id": "DB15277",
                        "description": "The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Gedivumab"
                    },
                    {
                        "drugbank-id": "DB15336",
                        "description": "The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Valanafusp alfa"
                    },
                    {
                        "drugbank-id": "DB15349",
                        "description": "The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Sofituzumab vedotin"
                    },
                    {
                        "drugbank-id": "DB15354",
                        "description": "The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Evinacumab"
                    },
                    {
                        "drugbank-id": "DB15363",
                        "description": "The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Istiratumab"
                    },
                    {
                        "drugbank-id": "DB15383",
                        "description": "The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Pidilizumab"
                    },
                    {
                        "drugbank-id": "DB15397",
                        "description": "The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with GMA 161"
                    },
                    {
                        "drugbank-id": "DB15409",
                        "description": "The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Ladiratuzumab vedotin"
                    },
                    {
                        "drugbank-id": "DB15415",
                        "description": "The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Tomaralimab"
                    },
                    {
                        "drugbank-id": "DB15428",
                        "description": "The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Vesencumab"
                    },
                    {
                        "drugbank-id": "DB15432",
                        "description": "The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Pinatuzumab vedotin"
                    },
                    {
                        "drugbank-id": "DB15441",
                        "description": "The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Lulizumab pegol"
                    },
                    {
                        "drugbank-id": "DB15443",
                        "description": "The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Lorukafusp alfa"
                    },
                    {
                        "drugbank-id": "DB15453",
                        "description": "The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Naratuximab emtansine"
                    },
                    {
                        "drugbank-id": "DB14004",
                        "description": "The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Tildrakizumab"
                    },
                    {
                        "drugbank-id": "DB05679",
                        "description": "The risk or severity of adverse effects can be increased when Ustekinumab is combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB12240",
                        "description": "The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Polatuzumab vedotin"
                    },
                    {
                        "drugbank-id": "DB15559",
                        "description": "The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Zenocutuzumab"
                    },
                    {
                        "drugbank-id": "DB15898",
                        "description": "The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Atoltivimab"
                    },
                    {
                        "drugbank-id": "DB15899",
                        "description": "The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Maftivimab"
                    },
                    {
                        "drugbank-id": "DB15900",
                        "description": "The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Odesivimab"
                    },
                    {
                        "drugbank-id": "DB01238",
                        "description": "The metabolism of Aripiprazole can be decreased when combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB14185",
                        "description": "The metabolism of Aripiprazole lauroxil can be decreased when combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB01234",
                        "description": "The metabolism of Brentuximab vedotin can be increased when combined with Dexamethasone"
                    },
                    {
                        "drugbank-id": "DB00252",
                        "description": "The metabolism of Brentuximab vedotin can be increased when combined with Phenytoin"
                    },
                    {
                        "drugbank-id": "DB00312",
                        "description": "The metabolism of Brentuximab vedotin can be increased when combined with Pentobarbital"
                    },
                    {
                        "drugbank-id": "DB00648",
                        "description": "The metabolism of Brentuximab vedotin can be increased when combined with Mitotane"
                    },
                    {
                        "drugbank-id": "DB00794",
                        "description": "The metabolism of Brentuximab vedotin can be increased when combined with Primidone"
                    },
                    {
                        "drugbank-id": "DB01174",
                        "description": "The metabolism of Brentuximab vedotin can be increased when combined with Phenobarbital"
                    },
                    {
                        "drugbank-id": "DB01220",
                        "description": "The metabolism of Brentuximab vedotin can be increased when combined with Rifaximin"
                    },
                    {
                        "drugbank-id": "DB06595",
                        "description": "The metabolism of Brentuximab vedotin can be increased when combined with Midostaurin"
                    },
                    {
                        "drugbank-id": "DB00307",
                        "description": "The metabolism of Brentuximab vedotin can be increased when combined with Bexarotene"
                    },
                    {
                        "drugbank-id": "DB00559",
                        "description": "The metabolism of Brentuximab vedotin can be increased when combined with Bosentan"
                    },
                    {
                        "drugbank-id": "DB00607",
                        "description": "The metabolism of Brentuximab vedotin can be increased when combined with Nafcillin"
                    },
                    {
                        "drugbank-id": "DB00625",
                        "description": "The metabolism of Brentuximab vedotin can be increased when combined with Efavirenz"
                    },
                    {
                        "drugbank-id": "DB06442",
                        "description": "The metabolism of Brentuximab vedotin can be increased when combined with Avasimibe"
                    },
                    {
                        "drugbank-id": "DB08912",
                        "description": "The metabolism of Brentuximab vedotin can be increased when combined with Dabrafenib"
                    },
                    {
                        "drugbank-id": "DB14240",
                        "description": "The metabolism of Brentuximab vedotin can be increased when combined with Echinacea"
                    },
                    {
                        "drugbank-id": "DB11767",
                        "description": "The metabolism of Sarilumab can be increased when combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB06201",
                        "description": "The metabolism of Rufinamide can be increased when combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB00273",
                        "description": "The metabolism of Brentuximab vedotin can be increased when combined with Topiramate"
                    },
                    {
                        "drugbank-id": "DB00615",
                        "description": "The metabolism of Brentuximab vedotin can be increased when combined with Rifabutin"
                    },
                    {
                        "drugbank-id": "DB00949",
                        "description": "The metabolism of Brentuximab vedotin can be increased when combined with Felbamate"
                    },
                    {
                        "drugbank-id": "DB01645",
                        "description": "The metabolism of Brentuximab vedotin can be increased when combined with Genistein"
                    },
                    {
                        "drugbank-id": "DB04911",
                        "description": "The metabolism of Brentuximab vedotin can be increased when combined with Oritavancin"
                    },
                    {
                        "drugbank-id": "DB08909",
                        "description": "The metabolism of Brentuximab vedotin can be increased when combined with Glycerol phenylbutyrate"
                    },
                    {
                        "drugbank-id": "DB09078",
                        "description": "The metabolism of Brentuximab vedotin can be increased when combined with Lenvatinib"
                    },
                    {
                        "drugbank-id": "DB09119",
                        "description": "The metabolism of Brentuximab vedotin can be increased when combined with Eslicarbazepine acetate"
                    },
                    {
                        "drugbank-id": "DB11560",
                        "description": "The metabolism of Brentuximab vedotin can be increased when combined with Lesinurad"
                    },
                    {
                        "drugbank-id": "DB11823",
                        "description": "The metabolism of Brentuximab vedotin can be increased when combined with Esketamine"
                    },
                    {
                        "drugbank-id": "DB00180",
                        "description": "The metabolism of Brentuximab vedotin can be increased when combined with Flunisolide"
                    },
                    {
                        "drugbank-id": "DB00443",
                        "description": "The metabolism of Brentuximab vedotin can be increased when combined with Betamethasone"
                    },
                    {
                        "drugbank-id": "DB00531",
                        "description": "The metabolism of Brentuximab vedotin can be increased when combined with Cyclophosphamide"
                    },
                    {
                        "drugbank-id": "DB00591",
                        "description": "The metabolism of Brentuximab vedotin can be increased when combined with Fluocinolone acetonide"
                    },
                    {
                        "drugbank-id": "DB00620",
                        "description": "The metabolism of Brentuximab vedotin can be increased when combined with Triamcinolone"
                    },
                    {
                        "drugbank-id": "DB00860",
                        "description": "The metabolism of Brentuximab vedotin can be increased when combined with Prednisolone"
                    },
                    {
                        "drugbank-id": "DB00959",
                        "description": "The metabolism of Brentuximab vedotin can be increased when combined with Methylprednisolone"
                    },
                    {
                        "drugbank-id": "DB01030",
                        "description": "The metabolism of Brentuximab vedotin can be increased when combined with Topotecan"
                    },
                    {
                        "drugbank-id": "DB01181",
                        "description": "The metabolism of Brentuximab vedotin can be increased when combined with Ifosfamide"
                    },
                    {
                        "drugbank-id": "DB01285",
                        "description": "The metabolism of Brentuximab vedotin can be increased when combined with Corticotropin"
                    },
                    {
                        "drugbank-id": "DB01380",
                        "description": "The metabolism of Brentuximab vedotin can be increased when combined with Cortisone acetate"
                    },
                    {
                        "drugbank-id": "DB01384",
                        "description": "The metabolism of Brentuximab vedotin can be increased when combined with Paramethasone"
                    },
                    {
                        "drugbank-id": "DB08906",
                        "description": "The metabolism of Fluticasone furoate can be increased when combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB08970",
                        "description": "The metabolism of Fluprednidene can be increased when combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB09383",
                        "description": "The metabolism of Meprednisone can be increased when combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB11487",
                        "description": "The metabolism of Dexamethasone isonicotinate can be increased when combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB11921",
                        "description": "The metabolism of Deflazacort can be increased when combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB13003",
                        "description": "The metabolism of Cortivazol can be increased when combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB13208",
                        "description": "The metabolism of Prednylidene can be increased when combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB13843",
                        "description": "The metabolism of Cloprednol can be increased when combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB13867",
                        "description": "The metabolism of Fluticasone can be increased when combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB14512",
                        "description": "The metabolism of Mometasone furoate can be increased when combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB14539",
                        "description": "The metabolism of Hydrocortisone acetate can be increased when combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB14545",
                        "description": "The metabolism of Hydrocortisone succinate can be increased when combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB09330",
                        "description": "The metabolism of Osimertinib can be increased when combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB13952",
                        "description": "The metabolism of Brentuximab vedotin can be increased when combined with Estradiol acetate"
                    },
                    {
                        "drugbank-id": "DB13953",
                        "description": "The metabolism of Brentuximab vedotin can be increased when combined with Estradiol benzoate"
                    },
                    {
                        "drugbank-id": "DB13954",
                        "description": "The metabolism of Brentuximab vedotin can be increased when combined with Estradiol cypionate"
                    },
                    {
                        "drugbank-id": "DB13956",
                        "description": "The metabolism of Brentuximab vedotin can be increased when combined with Estradiol valerate"
                    },
                    {
                        "drugbank-id": "DB00477",
                        "description": "The metabolism of Chlorpromazine can be increased when combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB06717",
                        "description": "The metabolism of Fosaprepitant can be increased when combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB00394",
                        "description": "The metabolism of Brentuximab vedotin can be increased when combined with Beclomethasone dipropionate"
                    },
                    {
                        "drugbank-id": "DB00773",
                        "description": "The metabolism of Brentuximab vedotin can be increased when combined with Etoposide"
                    },
                    {
                        "drugbank-id": "DB01222",
                        "description": "The metabolism of Brentuximab vedotin can be increased when combined with Budesonide"
                    },
                    {
                        "drugbank-id": "DB00454",
                        "description": "The metabolism of Meperidine can be increased when combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB00082",
                        "description": "The metabolism of Brentuximab vedotin can be increased when combined with Pegvisomant"
                    },
                    {
                        "drugbank-id": "DB00136",
                        "description": "The metabolism of Brentuximab vedotin can be increased when combined with Calcitriol"
                    },
                    {
                        "drugbank-id": "DB00163",
                        "description": "The metabolism of Brentuximab vedotin can be increased when combined with Vitamin E"
                    },
                    {
                        "drugbank-id": "DB00197",
                        "description": "The metabolism of Brentuximab vedotin can be increased when combined with Troglitazone"
                    },
                    {
                        "drugbank-id": "DB00241",
                        "description": "The metabolism of Brentuximab vedotin can be increased when combined with Butalbital"
                    },
                    {
                        "drugbank-id": "DB00301",
                        "description": "The metabolism of Brentuximab vedotin can be increased when combined with Flucloxacillin"
                    },
                    {
                        "drugbank-id": "DB00316",
                        "description": "The metabolism of Brentuximab vedotin can be increased when combined with Acetaminophen"
                    },
                    {
                        "drugbank-id": "DB00333",
                        "description": "The metabolism of Brentuximab vedotin can be increased when combined with Methadone"
                    },
                    {
                        "drugbank-id": "DB00338",
                        "description": "The metabolism of Brentuximab vedotin can be increased when combined with Omeprazole"
                    },
                    {
                        "drugbank-id": "DB00349",
                        "description": "The metabolism of Brentuximab vedotin can be increased when combined with Clobazam"
                    },
                    {
                        "drugbank-id": "DB00357",
                        "description": "The metabolism of Brentuximab vedotin can be increased when combined with Aminoglutethimide"
                    },
                    {
                        "drugbank-id": "DB00396",
                        "description": "The metabolism of Brentuximab vedotin can be increased when combined with Progesterone"
                    },
                    {
                        "drugbank-id": "DB00400",
                        "description": "The metabolism of Brentuximab vedotin can be increased when combined with Griseofulvin"
                    },
                    {
                        "drugbank-id": "DB00418",
                        "description": "The metabolism of Brentuximab vedotin can be increased when combined with Secobarbital"
                    },
                    {
                        "drugbank-id": "DB00439",
                        "description": "The metabolism of Brentuximab vedotin can be increased when combined with Cerivastatin"
                    },
                    {
                        "drugbank-id": "DB00448",
                        "description": "The metabolism of Brentuximab vedotin can be increased when combined with Lansoprazole"
                    },
                    {
                        "drugbank-id": "DB00474",
                        "description": "The metabolism of Brentuximab vedotin can be increased when combined with Methohexital"
                    },
                    {
                        "drugbank-id": "DB00485",
                        "description": "The metabolism of Brentuximab vedotin can be increased when combined with Dicloxacillin"
                    },
                    {
                        "drugbank-id": "DB00533",
                        "description": "The metabolism of Brentuximab vedotin can be increased when combined with Rofecoxib"
                    },
                    {
                        "drugbank-id": "DB00599",
                        "description": "The metabolism of Brentuximab vedotin can be increased when combined with Thiopental"
                    },
                    {
                        "drugbank-id": "DB00602",
                        "description": "The metabolism of Brentuximab vedotin can be increased when combined with Ivermectin"
                    },
                    {
                        "drugbank-id": "DB00603",
                        "description": "The metabolism of Brentuximab vedotin can be increased when combined with Medroxyprogesterone acetate"
                    },
                    {
                        "drugbank-id": "DB00624",
                        "description": "The metabolism of Brentuximab vedotin can be increased when combined with Testosterone"
                    },
                    {
                        "drugbank-id": "DB00636",
                        "description": "The metabolism of Brentuximab vedotin can be increased when combined with Clofibrate"
                    },
                    {
                        "drugbank-id": "DB00701",
                        "description": "The metabolism of Brentuximab vedotin can be increased when combined with Amprenavir"
                    },
                    {
                        "drugbank-id": "DB00741",
                        "description": "The metabolism of Brentuximab vedotin can be increased when combined with Hydrocortisone"
                    },
                    {
                        "drugbank-id": "DB00754",
                        "description": "The metabolism of Brentuximab vedotin can be increased when combined with Ethotoin"
                    },
                    {
                        "drugbank-id": "DB00769",
                        "description": "The metabolism of Brentuximab vedotin can be increased when combined with Hydrocortamate"
                    },
                    {
                        "drugbank-id": "DB00776",
                        "description": "The metabolism of Brentuximab vedotin can be increased when combined with Oxcarbazepine"
                    },
                    {
                        "drugbank-id": "DB00812",
                        "description": "The metabolism of Brentuximab vedotin can be increased when combined with Phenylbutazone"
                    },
                    {
                        "drugbank-id": "DB00849",
                        "description": "The metabolism of Brentuximab vedotin can be increased when combined with Methylphenobarbital"
                    },
                    {
                        "drugbank-id": "DB00857",
                        "description": "The metabolism of Brentuximab vedotin can be increased when combined with Terbinafine"
                    },
                    {
                        "drugbank-id": "DB00898",
                        "description": "The metabolism of Brentuximab vedotin can be increased when combined with Ethanol"
                    },
                    {
                        "drugbank-id": "DB01011",
                        "description": "The metabolism of Brentuximab vedotin can be increased when combined with Metyrapone"
                    },
                    {
                        "drugbank-id": "DB01032",
                        "description": "The metabolism of Brentuximab vedotin can be increased when combined with Probenecid"
                    },
                    {
                        "drugbank-id": "DB01083",
                        "description": "The metabolism of Brentuximab vedotin can be increased when combined with Orlistat"
                    },
                    {
                        "drugbank-id": "DB01115",
                        "description": "The metabolism of Brentuximab vedotin can be increased when combined with Nifedipine"
                    },
                    {
                        "drugbank-id": "DB01138",
                        "description": "The metabolism of Brentuximab vedotin can be increased when combined with Sulfinpyrazone"
                    },
                    {
                        "drugbank-id": "DB01154",
                        "description": "The metabolism of Brentuximab vedotin can be increased when combined with Thiamylal"
                    },
                    {
                        "drugbank-id": "DB01201",
                        "description": "The metabolism of Brentuximab vedotin can be increased when combined with Rifapentine"
                    },
                    {
                        "drugbank-id": "DB01221",
                        "description": "The metabolism of Brentuximab vedotin can be increased when combined with Ketamine"
                    },
                    {
                        "drugbank-id": "DB01333",
                        "description": "The metabolism of Brentuximab vedotin can be increased when combined with Cefradine"
                    },
                    {
                        "drugbank-id": "DB01351",
                        "description": "The metabolism of Brentuximab vedotin can be increased when combined with Amobarbital"
                    },
                    {
                        "drugbank-id": "DB01352",
                        "description": "The metabolism of Brentuximab vedotin can be increased when combined with Aprobarbital"
                    },
                    {
                        "drugbank-id": "DB01483",
                        "description": "The metabolism of Brentuximab vedotin can be increased when combined with Barbital"
                    },
                    {
                        "drugbank-id": "DB01609",
                        "description": "The metabolism of Brentuximab vedotin can be increased when combined with Deferasirox"
                    },
                    {
                        "drugbank-id": "DB04817",
                        "description": "The metabolism of Brentuximab vedotin can be increased when combined with Metamizole"
                    },
                    {
                        "drugbank-id": "DB04905",
                        "description": "The metabolism of Brentuximab vedotin can be increased when combined with Tesmilifene"
                    },
                    {
                        "drugbank-id": "DB04920",
                        "description": "The metabolism of Brentuximab vedotin can be increased when combined with Clevidipine"
                    },
                    {
                        "drugbank-id": "DB06708",
                        "description": "The metabolism of Brentuximab vedotin can be increased when combined with Lumefantrine"
                    },
                    {
                        "drugbank-id": "DB06739",
                        "description": "The metabolism of Brentuximab vedotin can be increased when combined with Seratrodast"
                    },
                    {
                        "drugbank-id": "DB08883",
                        "description": "The metabolism of Brentuximab vedotin can be increased when combined with Perampanel"
                    },
                    {
                        "drugbank-id": "DB08905",
                        "description": "The metabolism of Brentuximab vedotin can be increased when combined with Formestane"
                    },
                    {
                        "drugbank-id": "DB08911",
                        "description": "The metabolism of Brentuximab vedotin can be increased when combined with Trametinib"
                    },
                    {
                        "drugbank-id": "DB09001",
                        "description": "The metabolism of Brentuximab vedotin can be increased when combined with Barbexaclone"
                    },
                    {
                        "drugbank-id": "DB12267",
                        "description": "The metabolism of Brentuximab vedotin can be increased when combined with Brigatinib"
                    },
                    {
                        "drugbank-id": "DB13943",
                        "description": "The metabolism of Brentuximab vedotin can be increased when combined with Testosterone cypionate"
                    },
                    {
                        "drugbank-id": "DB13944",
                        "description": "The metabolism of Brentuximab vedotin can be increased when combined with Testosterone enanthate"
                    },
                    {
                        "drugbank-id": "DB13946",
                        "description": "The metabolism of Brentuximab vedotin can be increased when combined with Testosterone undecanoate"
                    },
                    {
                        "drugbank-id": "DB13955",
                        "description": "The metabolism of Brentuximab vedotin can be increased when combined with Estradiol dienanthate"
                    },
                    {
                        "drugbank-id": "DB14575",
                        "description": "The metabolism of Brentuximab vedotin can be increased when combined with Eslicarbazepine"
                    },
                    {
                        "drugbank-id": "DB14633",
                        "description": "The metabolism of Brentuximab vedotin can be increased when combined with Prednisolone hemisuccinate"
                    },
                    {
                        "drugbank-id": "DB14644",
                        "description": "The metabolism of Brentuximab vedotin can be increased when combined with Methylprednisolone hemisuccinate"
                    },
                    {
                        "drugbank-id": "DB14646",
                        "description": "The metabolism of Brentuximab vedotin can be increased when combined with Prednisone acetate"
                    },
                    {
                        "drugbank-id": "DB14652",
                        "description": "The metabolism of Brentuximab vedotin can be increased when combined with Clocortolone acetate"
                    },
                    {
                        "drugbank-id": "DB14659",
                        "description": "The metabolism of Brentuximab vedotin can be increased when combined with Melengestrol acetate"
                    },
                    {
                        "drugbank-id": "DB14669",
                        "description": "The metabolism of Brentuximab vedotin can be increased when combined with Betamethasone phosphate"
                    },
                    {
                        "drugbank-id": "DB14681",
                        "description": "The metabolism of Brentuximab vedotin can be increased when combined with Cortisone"
                    },
                    {
                        "drugbank-id": "DB01013",
                        "description": "The metabolism of Brentuximab vedotin can be increased when combined with Clobetasol propionate"
                    },
                    {
                        "drugbank-id": "DB01047",
                        "description": "The metabolism of Brentuximab vedotin can be increased when combined with Fluocinonide"
                    },
                    {
                        "drugbank-id": "DB14540",
                        "description": "The metabolism of Hydrocortisone butyrate can be increased when combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB00764",
                        "description": "The metabolism of Brentuximab vedotin can be increased when combined with Mometasone"
                    },
                    {
                        "drugbank-id": "DB08971",
                        "description": "The metabolism of Fluocortolone can be increased when combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB11750",
                        "description": "The metabolism of Clobetasol can be increased when combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB00342",
                        "description": "The metabolism of Brentuximab vedotin can be increased when combined with Terfenadine"
                    },
                    {
                        "drugbank-id": "DB00363",
                        "description": "The metabolism of Brentuximab vedotin can be increased when combined with Clozapine"
                    },
                    {
                        "drugbank-id": "DB15566",
                        "description": "The metabolism of Brentuximab vedotin can be increased when combined with Prednisolone acetate"
                    },
                    {
                        "drugbank-id": "DB09095",
                        "description": "The metabolism of Difluocortolone can be increased when combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB00763",
                        "description": "The metabolism of Brentuximab vedotin can be decreased when combined with Methimazole"
                    },
                    {
                        "drugbank-id": "DB11730",
                        "description": "The metabolism of Ribociclib can be decreased when combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB01072",
                        "description": "The metabolism of Atazanavir can be decreased when combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB00582",
                        "description": "The metabolism of Brentuximab vedotin can be decreased when combined with Voriconazole"
                    },
                    {
                        "drugbank-id": "DB00696",
                        "description": "The metabolism of Brentuximab vedotin can be decreased when combined with Ergotamine"
                    },
                    {
                        "drugbank-id": "DB00705",
                        "description": "The metabolism of Brentuximab vedotin can be decreased when combined with Delavirdine"
                    },
                    {
                        "drugbank-id": "DB00836",
                        "description": "The metabolism of Brentuximab vedotin can be decreased when combined with Loperamide"
                    },
                    {
                        "drugbank-id": "DB00976",
                        "description": "The metabolism of Brentuximab vedotin can be decreased when combined with Telithromycin"
                    },
                    {
                        "drugbank-id": "DB01149",
                        "description": "The metabolism of Brentuximab vedotin can be decreased when combined with Nefazodone"
                    },
                    {
                        "drugbank-id": "DB01183",
                        "description": "The metabolism of Brentuximab vedotin can be decreased when combined with Naloxone"
                    },
                    {
                        "drugbank-id": "DB01263",
                        "description": "The metabolism of Brentuximab vedotin can be decreased when combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB02520",
                        "description": "The metabolism of Brentuximab vedotin can be decreased when combined with Ditiocarb"
                    },
                    {
                        "drugbank-id": "DB08873",
                        "description": "The metabolism of Brentuximab vedotin can be decreased when combined with Boceprevir"
                    },
                    {
                        "drugbank-id": "DB09101",
                        "description": "The metabolism of Brentuximab vedotin can be decreased when combined with Elvitegravir"
                    },
                    {
                        "drugbank-id": "DB09118",
                        "description": "The metabolism of Brentuximab vedotin can be decreased when combined with Stiripentol"
                    },
                    {
                        "drugbank-id": "DB11779",
                        "description": "The metabolism of Brentuximab vedotin can be decreased when combined with Danoprevir"
                    },
                    {
                        "drugbank-id": "DB13179",
                        "description": "The metabolism of Brentuximab vedotin can be decreased when combined with Troleandomycin"
                    },
                    {
                        "drugbank-id": "DB00246",
                        "description": "The metabolism of Ziprasidone can be decreased when combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB00176",
                        "description": "The metabolism of Brentuximab vedotin can be decreased when combined with Fluvoxamine"
                    },
                    {
                        "drugbank-id": "DB00270",
                        "description": "The metabolism of Brentuximab vedotin can be decreased when combined with Isradipine"
                    },
                    {
                        "drugbank-id": "DB00343",
                        "description": "The metabolism of Brentuximab vedotin can be decreased when combined with Diltiazem"
                    },
                    {
                        "drugbank-id": "DB00537",
                        "description": "The metabolism of Brentuximab vedotin can be decreased when combined with Ciprofloxacin"
                    },
                    {
                        "drugbank-id": "DB00622",
                        "description": "The metabolism of Brentuximab vedotin can be decreased when combined with Nicardipine"
                    },
                    {
                        "drugbank-id": "DB00673",
                        "description": "The metabolism of Brentuximab vedotin can be decreased when combined with Aprepitant"
                    },
                    {
                        "drugbank-id": "DB00951",
                        "description": "The metabolism of Brentuximab vedotin can be decreased when combined with Isoniazid"
                    },
                    {
                        "drugbank-id": "DB01087",
                        "description": "The metabolism of Brentuximab vedotin can be decreased when combined with Primaquine"
                    },
                    {
                        "drugbank-id": "DB01110",
                        "description": "The metabolism of Brentuximab vedotin can be decreased when combined with Miconazole"
                    },
                    {
                        "drugbank-id": "DB01406",
                        "description": "The metabolism of Brentuximab vedotin can be decreased when combined with Danazol"
                    },
                    {
                        "drugbank-id": "DB02703",
                        "description": "The metabolism of Brentuximab vedotin can be decreased when combined with Fusidic acid"
                    },
                    {
                        "drugbank-id": "DB04832",
                        "description": "The metabolism of Brentuximab vedotin can be decreased when combined with Zimelidine"
                    },
                    {
                        "drugbank-id": "DB04896",
                        "description": "The metabolism of Brentuximab vedotin can be decreased when combined with Milnacipran"
                    },
                    {
                        "drugbank-id": "DB06700",
                        "description": "The metabolism of Brentuximab vedotin can be decreased when combined with Desvenlafaxine"
                    },
                    {
                        "drugbank-id": "DB06712",
                        "description": "The metabolism of Brentuximab vedotin can be decreased when combined with Nilvadipine"
                    },
                    {
                        "drugbank-id": "DB06731",
                        "description": "The metabolism of Brentuximab vedotin can be decreased when combined with Seproxetine"
                    },
                    {
                        "drugbank-id": "DB08953",
                        "description": "The metabolism of Brentuximab vedotin can be decreased when combined with Indalpine"
                    },
                    {
                        "drugbank-id": "DB09227",
                        "description": "The metabolism of Brentuximab vedotin can be decreased when combined with Barnidipine"
                    },
                    {
                        "drugbank-id": "DB09231",
                        "description": "The metabolism of Brentuximab vedotin can be decreased when combined with Benidipine"
                    },
                    {
                        "drugbank-id": "DB14019",
                        "description": "The metabolism of Brentuximab vedotin can be decreased when combined with Fosnetupitant"
                    },
                    {
                        "drugbank-id": "DB06589",
                        "description": "The metabolism of Brentuximab vedotin can be decreased when combined with Pazopanib"
                    },
                    {
                        "drugbank-id": "DB09074",
                        "description": "The metabolism of Olaparib can be decreased when combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB09063",
                        "description": "The metabolism of Ceritinib can be decreased when combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB00476",
                        "description": "The metabolism of Duloxetine can be decreased when combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB00215",
                        "description": "The metabolism of Brentuximab vedotin can be decreased when combined with Citalopram"
                    },
                    {
                        "drugbank-id": "DB00370",
                        "description": "The metabolism of Brentuximab vedotin can be decreased when combined with Mirtazapine"
                    },
                    {
                        "drugbank-id": "DB00501",
                        "description": "The metabolism of Brentuximab vedotin can be decreased when combined with Cimetidine"
                    },
                    {
                        "drugbank-id": "DB00778",
                        "description": "The metabolism of Brentuximab vedotin can be decreased when combined with Roxithromycin"
                    },
                    {
                        "drugbank-id": "DB00818",
                        "description": "The metabolism of Brentuximab vedotin can be decreased when combined with Propofol"
                    },
                    {
                        "drugbank-id": "DB00921",
                        "description": "The metabolism of Brentuximab vedotin can be decreased when combined with Buprenorphine"
                    },
                    {
                        "drugbank-id": "DB01016",
                        "description": "The metabolism of Brentuximab vedotin can be decreased when combined with Glyburide"
                    },
                    {
                        "drugbank-id": "DB01128",
                        "description": "The metabolism of Brentuximab vedotin can be decreased when combined with Bicalutamide"
                    },
                    {
                        "drugbank-id": "DB01173",
                        "description": "The metabolism of Brentuximab vedotin can be decreased when combined with Orphenadrine"
                    },
                    {
                        "drugbank-id": "DB01369",
                        "description": "The metabolism of Brentuximab vedotin can be decreased when combined with Quinupristin"
                    },
                    {
                        "drugbank-id": "DB01764",
                        "description": "The metabolism of Brentuximab vedotin can be decreased when combined with Dalfopristin"
                    },
                    {
                        "drugbank-id": "DB04839",
                        "description": "The metabolism of Brentuximab vedotin can be decreased when combined with Cyproterone acetate"
                    },
                    {
                        "drugbank-id": "DB04884",
                        "description": "The metabolism of Brentuximab vedotin can be decreased when combined with Dapoxetine"
                    },
                    {
                        "drugbank-id": "DB04894",
                        "description": "The metabolism of Brentuximab vedotin can be decreased when combined with Vapreotide"
                    },
                    {
                        "drugbank-id": "DB05928",
                        "description": "The metabolism of Brentuximab vedotin can be decreased when combined with Dovitinib"
                    },
                    {
                        "drugbank-id": "DB06663",
                        "description": "The metabolism of Brentuximab vedotin can be decreased when combined with Pasireotide"
                    },
                    {
                        "drugbank-id": "DB06791",
                        "description": "The metabolism of Brentuximab vedotin can be decreased when combined with Lanreotide"
                    },
                    {
                        "drugbank-id": "DB08864",
                        "description": "The metabolism of Brentuximab vedotin can be decreased when combined with Rilpivirine"
                    },
                    {
                        "drugbank-id": "DB09099",
                        "description": "The metabolism of Brentuximab vedotin can be decreased when combined with Somatostatin"
                    },
                    {
                        "drugbank-id": "DB09238",
                        "description": "The metabolism of Brentuximab vedotin can be decreased when combined with Manidipine"
                    },
                    {
                        "drugbank-id": "DB11837",
                        "description": "The metabolism of Brentuximab vedotin can be decreased when combined with Osilodrostat"
                    },
                    {
                        "drugbank-id": "DB13941",
                        "description": "The metabolism of Brentuximab vedotin can be decreased when combined with Piperaquine"
                    },
                    {
                        "drugbank-id": "DB04794",
                        "description": "The metabolism of Brentuximab vedotin can be decreased when combined with Bifonazole"
                    },
                    {
                        "drugbank-id": "DB00041",
                        "description": "The metabolism of Brentuximab vedotin can be decreased when combined with Aldesleukin"
                    },
                    {
                        "drugbank-id": "DB00188",
                        "description": "The metabolism of Brentuximab vedotin can be decreased when combined with Bortezomib"
                    },
                    {
                        "drugbank-id": "DB00309",
                        "description": "The metabolism of Brentuximab vedotin can be decreased when combined with Vindesine"
                    },
                    {
                        "drugbank-id": "DB00361",
                        "description": "The metabolism of Brentuximab vedotin can be decreased when combined with Vinorelbine"
                    },
                    {
                        "drugbank-id": "DB00444",
                        "description": "The metabolism of Brentuximab vedotin can be decreased when combined with Teniposide"
                    },
                    {
                        "drugbank-id": "DB00446",
                        "description": "The metabolism of Brentuximab vedotin can be decreased when combined with Chloramphenicol"
                    },
                    {
                        "drugbank-id": "DB00563",
                        "description": "The metabolism of Brentuximab vedotin can be decreased when combined with Methotrexate"
                    },
                    {
                        "drugbank-id": "DB00588",
                        "description": "The metabolism of Brentuximab vedotin can be decreased when combined with Fluticasone propionate"
                    },
                    {
                        "drugbank-id": "DB00762",
                        "description": "The metabolism of Brentuximab vedotin can be decreased when combined with Irinotecan"
                    },
                    {
                        "drugbank-id": "DB01248",
                        "description": "The metabolism of Brentuximab vedotin can be decreased when combined with Docetaxel"
                    },
                    {
                        "drugbank-id": "DB04572",
                        "description": "The metabolism of Brentuximab vedotin can be decreased when combined with Thiotepa"
                    },
                    {
                        "drugbank-id": "DB04845",
                        "description": "The metabolism of Brentuximab vedotin can be decreased when combined with Ixabepilone"
                    },
                    {
                        "drugbank-id": "DB05109",
                        "description": "The metabolism of Brentuximab vedotin can be decreased when combined with Trabectedin"
                    },
                    {
                        "drugbank-id": "DB05773",
                        "description": "The metabolism of Brentuximab vedotin can be decreased when combined with Trastuzumab emtansine"
                    },
                    {
                        "drugbank-id": "DB06603",
                        "description": "The metabolism of Brentuximab vedotin can be decreased when combined with Panobinostat"
                    },
                    {
                        "drugbank-id": "DB08877",
                        "description": "The metabolism of Ruxolitinib can be decreased when combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB08910",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB11817",
                        "description": "The metabolism of Baricitinib can be decreased when combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB00549",
                        "description": "The metabolism of Brentuximab vedotin can be decreased when combined with Zafirlukast"
                    },
                    {
                        "drugbank-id": "DB05239",
                        "description": "The metabolism of Cobimetinib can be decreased when combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB14009",
                        "description": "The metabolism of Medical Cannabis can be decreased when combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB00204",
                        "description": "The metabolism of Dofetilide can be decreased when combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB00277",
                        "description": "The metabolism of Theophylline can be decreased when combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB00946",
                        "description": "The metabolism of Phenprocoumon can be decreased when combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB01008",
                        "description": "The metabolism of Busulfan can be decreased when combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB01223",
                        "description": "The metabolism of Aminophylline can be decreased when combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB01396",
                        "description": "The metabolism of Digitoxin can be decreased when combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB09289",
                        "description": "The metabolism of Tianeptine can be decreased when combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB01320",
                        "description": "The metabolism of Fosphenytoin can be decreased when combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB00255",
                        "description": "The metabolism of Brentuximab vedotin can be decreased when combined with Diethylstilbestrol"
                    },
                    {
                        "drugbank-id": "DB06318",
                        "description": "The metabolism of Brentuximab vedotin can be decreased when combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB06342",
                        "description": "The metabolism of Brentuximab vedotin can be decreased when combined with Coltuximab ravtansine"
                    },
                    {
                        "drugbank-id": "DB12089",
                        "description": "The metabolism of Lorvotuzumab mertansine can be decreased when combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB12489",
                        "description": "The metabolism of Mirvetuximab Soravtansine can be decreased when combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB01100",
                        "description": "The metabolism of Pimozide can be decreased when combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB01151",
                        "description": "The metabolism of Desipramine can be decreased when combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB09054",
                        "description": "The metabolism of Idelalisib can be decreased when combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB12015",
                        "description": "The metabolism of Alpelisib can be decreased when combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB00564",
                        "description": "The metabolism of Carbamazepine can be decreased when combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB00877",
                        "description": "The metabolism of Sirolimus can be decreased when combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB01229",
                        "description": "The metabolism of Paclitaxel can be decreased when combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB01254",
                        "description": "The metabolism of Dasatinib can be decreased when combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB01590",
                        "description": "The metabolism of Everolimus can be decreased when combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB00541",
                        "description": "The metabolism of Brentuximab vedotin can be decreased when combined with Vincristine"
                    },
                    {
                        "drugbank-id": "DB00570",
                        "description": "The metabolism of Brentuximab vedotin can be decreased when combined with Vinblastine"
                    },
                    {
                        "drugbank-id": "DB00619",
                        "description": "The metabolism of Brentuximab vedotin can be decreased when combined with Imatinib"
                    },
                    {
                        "drugbank-id": "DB00694",
                        "description": "The metabolism of Brentuximab vedotin can be decreased when combined with Daunorubicin"
                    },
                    {
                        "drugbank-id": "DB00997",
                        "description": "The metabolism of Brentuximab vedotin can be decreased when combined with Doxorubicin"
                    },
                    {
                        "drugbank-id": "DB01204",
                        "description": "The metabolism of Brentuximab vedotin can be decreased when combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB01268",
                        "description": "The metabolism of Brentuximab vedotin can be decreased when combined with Sunitinib"
                    },
                    {
                        "drugbank-id": "DB06616",
                        "description": "The metabolism of Brentuximab vedotin can be decreased when combined with Bosutinib"
                    },
                    {
                        "drugbank-id": "DB06772",
                        "description": "The metabolism of Brentuximab vedotin can be decreased when combined with Cabazitaxel"
                    },
                    {
                        "drugbank-id": "DB12371",
                        "description": "The metabolism of Siponimod can be decreased when combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB00637",
                        "description": "The metabolism of Astemizole can be decreased when combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB11363",
                        "description": "The metabolism of Alectinib can be decreased when combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB11641",
                        "description": "The metabolism of Vinflunine can be decreased when combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB11703",
                        "description": "The metabolism of Acalabrutinib can be decreased when combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB15035",
                        "description": "The metabolism of Zanubrutinib can be decreased when combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB00248",
                        "description": "The metabolism of Brentuximab vedotin can be decreased when combined with Cabergoline"
                    },
                    {
                        "drugbank-id": "DB00254",
                        "description": "The metabolism of Brentuximab vedotin can be decreased when combined with Doxycycline"
                    },
                    {
                        "drugbank-id": "DB00313",
                        "description": "The metabolism of Brentuximab vedotin can be decreased when combined with Valproic acid"
                    },
                    {
                        "drugbank-id": "DB00317",
                        "description": "The metabolism of Brentuximab vedotin can be decreased when combined with Gefitinib"
                    },
                    {
                        "drugbank-id": "DB00320",
                        "description": "The metabolism of Brentuximab vedotin can be decreased when combined with Dihydroergotamine"
                    },
                    {
                        "drugbank-id": "DB00353",
                        "description": "The metabolism of Brentuximab vedotin can be decreased when combined with Methylergometrine"
                    },
                    {
                        "drugbank-id": "DB00358",
                        "description": "The metabolism of Brentuximab vedotin can be decreased when combined with Mefloquine"
                    },
                    {
                        "drugbank-id": "DB00435",
                        "description": "The metabolism of Brentuximab vedotin can be decreased when combined with Nitric Oxide"
                    },
                    {
                        "drugbank-id": "DB00481",
                        "description": "The metabolism of Brentuximab vedotin can be decreased when combined with Raloxifene"
                    },
                    {
                        "drugbank-id": "DB00530",
                        "description": "The metabolism of Brentuximab vedotin can be decreased when combined with Erlotinib"
                    },
                    {
                        "drugbank-id": "DB00627",
                        "description": "The metabolism of Brentuximab vedotin can be decreased when combined with Niacin"
                    },
                    {
                        "drugbank-id": "DB00647",
                        "description": "The metabolism of Brentuximab vedotin can be decreased when combined with Dextropropoxyphene"
                    },
                    {
                        "drugbank-id": "DB00668",
                        "description": "The metabolism of Brentuximab vedotin can be decreased when combined with Epinephrine"
                    },
                    {
                        "drugbank-id": "DB00678",
                        "description": "The metabolism of Brentuximab vedotin can be decreased when combined with Losartan"
                    },
                    {
                        "drugbank-id": "DB00681",
                        "description": "The metabolism of Brentuximab vedotin can be decreased when combined with Amphotericin B"
                    },
                    {
                        "drugbank-id": "DB00715",
                        "description": "The metabolism of Brentuximab vedotin can be decreased when combined with Paroxetine"
                    },
                    {
                        "drugbank-id": "DB00752",
                        "description": "The metabolism of Brentuximab vedotin can be decreased when combined with Tranylcypromine"
                    },
                    {
                        "drugbank-id": "DB00759",
                        "description": "The metabolism of Brentuximab vedotin can be decreased when combined with Tetracycline"
                    },
                    {
                        "drugbank-id": "DB00780",
                        "description": "The metabolism of Brentuximab vedotin can be decreased when combined with Phenelzine"
                    },
                    {
                        "drugbank-id": "DB00819",
                        "description": "The metabolism of Brentuximab vedotin can be decreased when combined with Acetazolamide"
                    },
                    {
                        "drugbank-id": "DB00829",
                        "description": "The metabolism of Brentuximab vedotin can be decreased when combined with Diazepam"
                    },
                    {
                        "drugbank-id": "DB00916",
                        "description": "The metabolism of Brentuximab vedotin can be decreased when combined with Metronidazole"
                    },
                    {
                        "drugbank-id": "DB00954",
                        "description": "The metabolism of Brentuximab vedotin can be decreased when combined with Dirithromycin"
                    },
                    {
                        "drugbank-id": "DB01023",
                        "description": "The metabolism of Brentuximab vedotin can be decreased when combined with Felodipine"
                    },
                    {
                        "drugbank-id": "DB01029",
                        "description": "The metabolism of Brentuximab vedotin can be decreased when combined with Irbesartan"
                    },
                    {
                        "drugbank-id": "DB01059",
                        "description": "The metabolism of Brentuximab vedotin can be decreased when combined with Norfloxacin"
                    },
                    {
                        "drugbank-id": "DB01062",
                        "description": "The metabolism of Brentuximab vedotin can be decreased when combined with Oxybutynin"
                    },
                    {
                        "drugbank-id": "DB01071",
                        "description": "The metabolism of Brentuximab vedotin can be decreased when combined with Mequitazine"
                    },
                    {
                        "drugbank-id": "DB01085",
                        "description": "The metabolism of Brentuximab vedotin can be decreased when combined with Pilocarpine"
                    },
                    {
                        "drugbank-id": "DB01093",
                        "description": "The metabolism of Brentuximab vedotin can be decreased when combined with Dimethyl sulfoxide"
                    },
                    {
                        "drugbank-id": "DB01095",
                        "description": "The metabolism of Brentuximab vedotin can be decreased when combined with Fluvastatin"
                    },
                    {
                        "drugbank-id": "DB01129",
                        "description": "The metabolism of Brentuximab vedotin can be decreased when combined with Rabeprazole"
                    },
                    {
                        "drugbank-id": "DB01152",
                        "description": "The metabolism of Brentuximab vedotin can be decreased when combined with Candicidin"
                    },
                    {
                        "drugbank-id": "DB01200",
                        "description": "The metabolism of Brentuximab vedotin can be decreased when combined with Bromocriptine"
                    },
                    {
                        "drugbank-id": "DB01275",
                        "description": "The metabolism of Brentuximab vedotin can be decreased when combined with Hydralazine"
                    },
                    {
                        "drugbank-id": "DB01587",
                        "description": "The metabolism of Brentuximab vedotin can be decreased when combined with Ketazolam"
                    },
                    {
                        "drugbank-id": "DB01628",
                        "description": "The metabolism of Brentuximab vedotin can be decreased when combined with Etoricoxib"
                    },
                    {
                        "drugbank-id": "DB01685",
                        "description": "The metabolism of Brentuximab vedotin can be decreased when combined with Topiroxostat"
                    },
                    {
                        "drugbank-id": "DB01698",
                        "description": "The metabolism of Brentuximab vedotin can be decreased when combined with Rutin"
                    },
                    {
                        "drugbank-id": "DB01873",
                        "description": "The metabolism of Brentuximab vedotin can be decreased when combined with Epothilone D"
                    },
                    {
                        "drugbank-id": "DB02709",
                        "description": "The metabolism of Brentuximab vedotin can be decreased when combined with Resveratrol"
                    },
                    {
                        "drugbank-id": "DB03010",
                        "description": "The metabolism of Brentuximab vedotin can be decreased when combined with Patupilone"
                    },
                    {
                        "drugbank-id": "DB04070",
                        "description": "The metabolism of Brentuximab vedotin can be decreased when combined with 6 Deoxyerythronolide B"
                    },
                    {
                        "drugbank-id": "DB05482",
                        "description": "The metabolism of Brentuximab vedotin can be decreased when combined with 7 ethyl 10 hydroxycamptothecin"
                    },
                    {
                        "drugbank-id": "DB05814",
                        "description": "The metabolism of Brentuximab vedotin can be decreased when combined with GPI 1485"
                    },
                    {
                        "drugbank-id": "DB05903",
                        "description": "The metabolism of Brentuximab vedotin can be decreased when combined with KOS 1584"
                    },
                    {
                        "drugbank-id": "DB06174",
                        "description": "The metabolism of Brentuximab vedotin can be decreased when combined with Noscapine"
                    },
                    {
                        "drugbank-id": "DB06233",
                        "description": "The metabolism of Brentuximab vedotin can be decreased when combined with Ridaforolimus"
                    },
                    {
                        "drugbank-id": "DB06268",
                        "description": "The metabolism of Brentuximab vedotin can be decreased when combined with Sitaxentan"
                    },
                    {
                        "drugbank-id": "DB06370",
                        "description": "The metabolism of Brentuximab vedotin can be decreased when combined with Indisulam"
                    },
                    {
                        "drugbank-id": "DB06412",
                        "description": "The metabolism of Brentuximab vedotin can be decreased when combined with Oxymetholone"
                    },
                    {
                        "drugbank-id": "DB06419",
                        "description": "The metabolism of Brentuximab vedotin can be decreased when combined with Cethromycin"
                    },
                    {
                        "drugbank-id": "DB06458",
                        "description": "The metabolism of Brentuximab vedotin can be decreased when combined with Remacemide"
                    },
                    {
                        "drugbank-id": "DB06469",
                        "description": "The metabolism of Brentuximab vedotin can be decreased when combined with Lestaurtinib"
                    },
                    {
                        "drugbank-id": "DB06587",
                        "description": "The metabolism of Brentuximab vedotin can be decreased when combined with Mitemcinal"
                    },
                    {
                        "drugbank-id": "DB06774",
                        "description": "The metabolism of Brentuximab vedotin can be decreased when combined with Capsaicin"
                    },
                    {
                        "drugbank-id": "DB08811",
                        "description": "The metabolism of Brentuximab vedotin can be decreased when combined with Tofisopam"
                    },
                    {
                        "drugbank-id": "DB06626",
                        "description": "The metabolism of Axitinib can be decreased when combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB09143",
                        "description": "The metabolism of Sonidegib can be decreased when combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB09570",
                        "description": "The metabolism of Ixazomib can be decreased when combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB12483",
                        "description": "The metabolism of Copanlisib can be decreased when combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB12978",
                        "description": "The metabolism of Pexidartinib can be decreased when combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB09235",
                        "description": "The metabolism of Brentuximab vedotin can be decreased when combined with Efonidipine"
                    },
                    {
                        "drugbank-id": "DB09308",
                        "description": "The metabolism of Brentuximab vedotin can be decreased when combined with Solithromycin"
                    },
                    {
                        "drugbank-id": "DB09309",
                        "description": "The metabolism of Brentuximab vedotin can be decreased when combined with Kitasamycin"
                    },
                    {
                        "drugbank-id": "DB11198",
                        "description": "The metabolism of Brentuximab vedotin can be decreased when combined with Peppermint oil"
                    },
                    {
                        "drugbank-id": "DB11383",
                        "description": "The metabolism of Brentuximab vedotin can be decreased when combined with Carbomycin"
                    },
                    {
                        "drugbank-id": "DB11400",
                        "description": "The metabolism of Brentuximab vedotin can be decreased when combined with Doramectin"
                    },
                    {
                        "drugbank-id": "DB11405",
                        "description": "The metabolism of Brentuximab vedotin can be decreased when combined with Eprinomectin"
                    },
                    {
                        "drugbank-id": "DB11442",
                        "description": "The metabolism of Brentuximab vedotin can be decreased when combined with Oleandomycin"
                    },
                    {
                        "drugbank-id": "DB11459",
                        "description": "The metabolism of Brentuximab vedotin can be decreased when combined with Selamectin"
                    },
                    {
                        "drugbank-id": "DB11470",
                        "description": "The metabolism of Brentuximab vedotin can be decreased when combined with Tildipirosin"
                    },
                    {
                        "drugbank-id": "DB11471",
                        "description": "The metabolism of Brentuximab vedotin can be decreased when combined with Tilmicosin"
                    },
                    {
                        "drugbank-id": "DB11475",
                        "description": "The metabolism of Brentuximab vedotin can be decreased when combined with Tylosin"
                    },
                    {
                        "drugbank-id": "DB11554",
                        "description": "The metabolism of Brentuximab vedotin can be decreased when combined with Tylvalosin"
                    },
                    {
                        "drugbank-id": "DB11574",
                        "description": "The metabolism of Brentuximab vedotin can be decreased when combined with Elbasvir"
                    },
                    {
                        "drugbank-id": "DB11752",
                        "description": "The metabolism of Brentuximab vedotin can be decreased when combined with Bryostatin 1"
                    },
                    {
                        "drugbank-id": "DB11805",
                        "description": "The metabolism of Brentuximab vedotin can be decreased when combined with Saracatinib"
                    },
                    {
                        "drugbank-id": "DB12010",
                        "description": "The metabolism of Brentuximab vedotin can be decreased when combined with Fostamatinib"
                    },
                    {
                        "drugbank-id": "DB12070",
                        "description": "The metabolism of Brentuximab vedotin can be decreased when combined with Letermovir"
                    },
                    {
                        "drugbank-id": "DB12245",
                        "description": "The metabolism of Brentuximab vedotin can be decreased when combined with Triclabendazole"
                    },
                    {
                        "drugbank-id": "DB12266",
                        "description": "The metabolism of Brentuximab vedotin can be decreased when combined with Epofolate"
                    },
                    {
                        "drugbank-id": "DB12391",
                        "description": "The metabolism of Brentuximab vedotin can be decreased when combined with Sagopilone"
                    },
                    {
                        "drugbank-id": "DB12532",
                        "description": "The metabolism of Brentuximab vedotin can be decreased when combined with Oxetacaine"
                    },
                    {
                        "drugbank-id": "DB13287",
                        "description": "The metabolism of Brentuximab vedotin can be decreased when combined with Miocamycin"
                    },
                    {
                        "drugbank-id": "DB13338",
                        "description": "The metabolism of Brentuximab vedotin can be decreased when combined with Flurithromycin"
                    },
                    {
                        "drugbank-id": "DB13409",
                        "description": "The metabolism of Brentuximab vedotin can be decreased when combined with Rokitamycin"
                    },
                    {
                        "drugbank-id": "DB13456",
                        "description": "The metabolism of Brentuximab vedotin can be decreased when combined with Midecamycin"
                    },
                    {
                        "drugbank-id": "DB13950",
                        "description": "The metabolism of Brentuximab vedotin can be decreased when combined with WIN 55212 2"
                    },
                    {
                        "drugbank-id": "DB13975",
                        "description": "The metabolism of Brentuximab vedotin can be decreased when combined with Black cohosh"
                    },
                    {
                        "drugbank-id": "DB14635",
                        "description": "The metabolism of Brentuximab vedotin can be decreased when combined with Curcumin sulfate"
                    },
                    {
                        "drugbank-id": "DB06176",
                        "description": "The metabolism of Brentuximab vedotin can be decreased when combined with Romidepsin"
                    },
                    {
                        "drugbank-id": "DB06212",
                        "description": "The metabolism of Brentuximab vedotin can be decreased when combined with Tolvaptan"
                    },
                    {
                        "drugbank-id": "DB13633",
                        "description": "The metabolism of Brentuximab vedotin can be decreased when combined with Mepartricin"
                    },
                    {
                        "drugbank-id": "DB00575",
                        "description": "The metabolism of Clonidine can be decreased when combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB12001",
                        "description": "The metabolism of Abemaciclib can be decreased when combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB00540",
                        "description": "The metabolism of Nortriptyline can be decreased when combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB01227",
                        "description": "The metabolism of Levacetylmethadol can be decreased when combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB01242",
                        "description": "The metabolism of Clomipramine can be decreased when combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB00186",
                        "description": "The metabolism of Lorazepam can be decreased when combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB00191",
                        "description": "The metabolism of Phentermine can be decreased when combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB00208",
                        "description": "The metabolism of Ticlopidine can be decreased when combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB00264",
                        "description": "The metabolism of Metoprolol can be decreased when combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB00426",
                        "description": "The metabolism of Famciclovir can be decreased when combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB00433",
                        "description": "The metabolism of Prochlorperazine can be decreased when combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB00567",
                        "description": "The metabolism of Cephalexin can be decreased when combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB01098",
                        "description": "The metabolism of Rosuvastatin can be decreased when combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB01411",
                        "description": "The metabolism of Pranlukast can be decreased when combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB01431",
                        "description": "The metabolism of Allylestrenol can be decreased when combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB01624",
                        "description": "The metabolism of Zuclopenthixol can be decreased when combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB06218",
                        "description": "The metabolism of Lacosamide can be decreased when combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB09071",
                        "description": "The metabolism of Tasimelteon can be decreased when combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB09079",
                        "description": "The metabolism of Nintedanib can be decreased when combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB09299",
                        "description": "The metabolism of Tenofovir alafenamide can be decreased when combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB11094",
                        "description": "The metabolism of Vitamin D can be decreased when combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB11273",
                        "description": "The metabolism of Dihydroergocornine can be decreased when combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB11952",
                        "description": "The metabolism of Duvelisib can be decreased when combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB12141",
                        "description": "The metabolism of Gilteritinib can be decreased when combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB12515",
                        "description": "The metabolism of 9 aminocamptothecin can be decreased when combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB12952",
                        "description": "The metabolism of Methylprednisone can be decreased when combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB13345",
                        "description": "The metabolism of Dihydroergocristine can be decreased when combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB13385",
                        "description": "The metabolism of Dihydroergocryptine can be decreased when combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB14126",
                        "description": "The metabolism of Tenofovir can be decreased when combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB01395",
                        "description": "The metabolism of Drospirenone can be decreased when combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB15444",
                        "description": "The metabolism of Elexacaftor can be decreased when combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB00717",
                        "description": "The metabolism of Norethisterone can be decreased when combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB12887",
                        "description": "The metabolism of Tazemetostat can be decreased when combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB00207",
                        "description": "The metabolism of Azithromycin can be decreased when combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB00518",
                        "description": "The metabolism of Albendazole can be decreased when combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB00590",
                        "description": "The metabolism of Doxazosin can be decreased when combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB01039",
                        "description": "The metabolism of Fenofibrate can be decreased when combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB00247",
                        "description": "The metabolism of Methysergide can be decreased when combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB11742",
                        "description": "The metabolism of Ebastine can be decreased when combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB00604",
                        "description": "The metabolism of Brentuximab vedotin can be decreased when combined with Cisapride"
                    },
                    {
                        "drugbank-id": "DB00005",
                        "description": "The metabolism of Brentuximab vedotin can be increased when combined with Etanercept"
                    },
                    {
                        "drugbank-id": "DB00026",
                        "description": "The metabolism of Brentuximab vedotin can be increased when combined with Anakinra"
                    },
                    {
                        "drugbank-id": "DB00051",
                        "description": "The metabolism of Brentuximab vedotin can be increased when combined with Adalimumab"
                    },
                    {
                        "drugbank-id": "DB00065",
                        "description": "The metabolism of Brentuximab vedotin can be increased when combined with Infliximab"
                    },
                    {
                        "drugbank-id": "DB01281",
                        "description": "The metabolism of Brentuximab vedotin can be increased when combined with Abatacept"
                    },
                    {
                        "drugbank-id": "DB04956",
                        "description": "The metabolism of Brentuximab vedotin can be increased when combined with Afelimomab"
                    },
                    {
                        "drugbank-id": "DB05676",
                        "description": "The metabolism of Brentuximab vedotin can be increased when combined with Apremilast"
                    },
                    {
                        "drugbank-id": "DB06168",
                        "description": "The metabolism of Brentuximab vedotin can be increased when combined with Canakinumab"
                    },
                    {
                        "drugbank-id": "DB06273",
                        "description": "The metabolism of Brentuximab vedotin can be increased when combined with Tocilizumab"
                    },
                    {
                        "drugbank-id": "DB06372",
                        "description": "The metabolism of Brentuximab vedotin can be increased when combined with Rilonacept"
                    },
                    {
                        "drugbank-id": "DB06674",
                        "description": "The metabolism of Brentuximab vedotin can be increased when combined with Golimumab"
                    },
                    {
                        "drugbank-id": "DB08904",
                        "description": "The metabolism of Certolizumab pegol can be increased when combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB09029",
                        "description": "The metabolism of Secukinumab can be increased when combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB09036",
                        "description": "The metabolism of Siltuximab can be increased when combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB14724",
                        "description": "The metabolism of Emapalumab can be increased when combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB05889",
                        "description": "The serum concentration of Brentuximab vedotin can be increased when it is combined with Inotuzumab ozogamicin"
                    },
                    {
                        "drugbank-id": "DB00175",
                        "description": "The serum concentration of Brentuximab vedotin can be increased when it is combined with Pravastatin"
                    },
                    {
                        "drugbank-id": "DB00295",
                        "description": "The serum concentration of Brentuximab vedotin can be increased when it is combined with Morphine"
                    },
                    {
                        "drugbank-id": "DB00300",
                        "description": "The serum concentration of Brentuximab vedotin can be increased when it is combined with Tenofovir disoproxil"
                    },
                    {
                        "drugbank-id": "DB00390",
                        "description": "The serum concentration of Brentuximab vedotin can be increased when it is combined with Digoxin"
                    },
                    {
                        "drugbank-id": "DB00612",
                        "description": "The serum concentration of Brentuximab vedotin can be increased when it is combined with Bisoprolol"
                    },
                    {
                        "drugbank-id": "DB00742",
                        "description": "The serum concentration of Brentuximab vedotin can be increased when it is combined with Mannitol"
                    },
                    {
                        "drugbank-id": "DB00882",
                        "description": "The serum concentration of Brentuximab vedotin can be increased when it is combined with Clomifene"
                    },
                    {
                        "drugbank-id": "DB00950",
                        "description": "The serum concentration of Brentuximab vedotin can be increased when it is combined with Fexofenadine"
                    },
                    {
                        "drugbank-id": "DB01079",
                        "description": "The serum concentration of Brentuximab vedotin can be increased when it is combined with Tegaserod"
                    },
                    {
                        "drugbank-id": "DB01261",
                        "description": "The serum concentration of Brentuximab vedotin can be increased when it is combined with Sitagliptin"
                    },
                    {
                        "drugbank-id": "DB05039",
                        "description": "The serum concentration of Brentuximab vedotin can be increased when it is combined with Indacaterol"
                    },
                    {
                        "drugbank-id": "DB06207",
                        "description": "The serum concentration of Brentuximab vedotin can be increased when it is combined with Silodosin"
                    },
                    {
                        "drugbank-id": "DB06228",
                        "description": "The serum concentration of Brentuximab vedotin can be increased when it is combined with Rivaroxaban"
                    },
                    {
                        "drugbank-id": "DB06403",
                        "description": "The serum concentration of Brentuximab vedotin can be increased when it is combined with Ambrisentan"
                    },
                    {
                        "drugbank-id": "DB06605",
                        "description": "The serum concentration of Brentuximab vedotin can be increased when it is combined with Apixaban"
                    },
                    {
                        "drugbank-id": "DB06670",
                        "description": "The serum concentration of Brentuximab vedotin can be increased when it is combined with Odanacatib"
                    },
                    {
                        "drugbank-id": "DB06695",
                        "description": "The serum concentration of Brentuximab vedotin can be increased when it is combined with Dabigatran etexilate"
                    },
                    {
                        "drugbank-id": "DB08930",
                        "description": "The serum concentration of Brentuximab vedotin can be increased when it is combined with Dolutegravir"
                    },
                    {
                        "drugbank-id": "DB08934",
                        "description": "The serum concentration of Brentuximab vedotin can be increased when it is combined with Sofosbuvir"
                    },
                    {
                        "drugbank-id": "DB09075",
                        "description": "The serum concentration of Brentuximab vedotin can be increased when it is combined with Edoxaban"
                    },
                    {
                        "drugbank-id": "DB09076",
                        "description": "The serum concentration of Brentuximab vedotin can be increased when it is combined with Umeclidinium"
                    },
                    {
                        "drugbank-id": "DB09161",
                        "description": "The serum concentration of Brentuximab vedotin can be increased when it is combined with Technetium Tc 99m sestamibi"
                    },
                    {
                        "drugbank-id": "DB09183",
                        "description": "The serum concentration of Brentuximab vedotin can be increased when it is combined with Dasabuvir"
                    },
                    {
                        "drugbank-id": "DB09296",
                        "description": "The serum concentration of Brentuximab vedotin can be increased when it is combined with Ombitasvir"
                    },
                    {
                        "drugbank-id": "DB09297",
                        "description": "The serum concentration of Brentuximab vedotin can be increased when it is combined with Paritaprevir"
                    },
                    {
                        "drugbank-id": "DB11362",
                        "description": "The serum concentration of Brentuximab vedotin can be increased when it is combined with Selexipag"
                    },
                    {
                        "drugbank-id": "DB11575",
                        "description": "The serum concentration of Brentuximab vedotin can be increased when it is combined with Grazoprevir"
                    },
                    {
                        "drugbank-id": "DB11689",
                        "description": "The serum concentration of Brentuximab vedotin can be increased when it is combined with Selumetinib"
                    },
                    {
                        "drugbank-id": "DB11712",
                        "description": "The serum concentration of Brentuximab vedotin can be increased when it is combined with Tezacaftor"
                    },
                    {
                        "drugbank-id": "DB11760",
                        "description": "The serum concentration of Brentuximab vedotin can be increased when it is combined with Talazoparib"
                    },
                    {
                        "drugbank-id": "DB11770",
                        "description": "The serum concentration of Brentuximab vedotin can be increased when it is combined with Talinolol"
                    },
                    {
                        "drugbank-id": "DB11827",
                        "description": "The serum concentration of Brentuximab vedotin can be increased when it is combined with Ertugliflozin"
                    },
                    {
                        "drugbank-id": "DB11855",
                        "description": "The serum concentration of Brentuximab vedotin can be increased when it is combined with Revefenacin"
                    },
                    {
                        "drugbank-id": "DB11951",
                        "description": "The serum concentration of Brentuximab vedotin can be increased when it is combined with Lemborexant"
                    },
                    {
                        "drugbank-id": "DB11995",
                        "description": "The serum concentration of Brentuximab vedotin can be increased when it is combined with Avatrombopag"
                    },
                    {
                        "drugbank-id": "DB12364",
                        "description": "The serum concentration of Brentuximab vedotin can be increased when it is combined with Betrixaban"
                    },
                    {
                        "drugbank-id": "DB12455",
                        "description": "The serum concentration of Brentuximab vedotin can be increased when it is combined with Omadacycline"
                    },
                    {
                        "drugbank-id": "DB12457",
                        "description": "The serum concentration of Brentuximab vedotin can be increased when it is combined with Rimegepant"
                    },
                    {
                        "drugbank-id": "DB12836",
                        "description": "The serum concentration of Brentuximab vedotin can be increased when it is combined with Grapiprant"
                    },
                    {
                        "drugbank-id": "DB12941",
                        "description": "The serum concentration of Brentuximab vedotin can be increased when it is combined with Darolutamide"
                    },
                    {
                        "drugbank-id": "DB13007",
                        "description": "The serum concentration of Brentuximab vedotin can be increased when it is combined with Enfortumab vedotin"
                    },
                    {
                        "drugbank-id": "DB13125",
                        "description": "The serum concentration of Brentuximab vedotin can be increased when it is combined with Lusutrombopag"
                    },
                    {
                        "drugbank-id": "DB14723",
                        "description": "The serum concentration of Brentuximab vedotin can be increased when it is combined with Larotrectinib"
                    },
                    {
                        "drugbank-id": "DB15328",
                        "description": "The serum concentration of Brentuximab vedotin can be increased when it is combined with Ubrogepant"
                    },
                    {
                        "drugbank-id": "DB11796",
                        "description": "The serum concentration of Brentuximab vedotin can be increased when it is combined with Fostemsavir"
                    },
                    {
                        "drugbank-id": "DB14761",
                        "description": "The serum concentration of Brentuximab vedotin can be increased when it is combined with Remdesivir"
                    },
                    {
                        "drugbank-id": "DB15719",
                        "description": "The serum concentration of Belantamab mafodotin can be increased when it is combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB06480",
                        "description": "The metabolism of Prucalopride can be decreased when combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB00091",
                        "description": "Brentuximab vedotin may increase the immunosuppressive activities of Cyclosporine"
                    },
                    {
                        "drugbank-id": "DB12147",
                        "description": "The serum concentration of Brentuximab vedotin can be increased when it is combined with Erdafitinib"
                    },
                    {
                        "drugbank-id": "DB12825",
                        "description": "The serum concentration of Lefamulin can be increased when it is combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB14975",
                        "description": "The serum concentration of Voxelotor can be increased when it is combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB06119",
                        "description": "The serum concentration of Brentuximab vedotin can be decreased when it is combined with Cenobamate"
                    },
                    {
                        "drugbank-id": "DB09237",
                        "description": "The serum concentration of Levamlodipine can be increased when it is combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB15595",
                        "description": "The therapeutic efficacy of Ebola Zaire vaccine live attenuated can be decreased when used in combination with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB00193",
                        "description": "The metabolism of Tramadol can be decreased when combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB01264",
                        "description": "The serum concentration of Brentuximab vedotin can be increased when it is combined with Darunavir"
                    },
                    {
                        "drugbank-id": "DB14513",
                        "description": "The serum concentration of Magnesium can be decreased when it is combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB01601",
                        "description": "The serum concentration of Brentuximab vedotin can be increased when it is combined with Lopinavir"
                    },
                    {
                        "drugbank-id": "DB00503",
                        "description": "The serum concentration of Brentuximab vedotin can be increased when it is combined with Ritonavir"
                    },
                    {
                        "drugbank-id": "DB00502",
                        "description": "The serum concentration of Haloperidol can be increased when it is combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB11652",
                        "description": "The metabolism of Tucatinib can be decreased when combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB11791",
                        "description": "The serum concentration of Brentuximab vedotin can be increased when it is combined with Capmatinib"
                    },
                    {
                        "drugbank-id": "DB12530",
                        "description": "The risk or severity of infection can be increased when Brentuximab vedotin is combined with Inebilizumab"
                    },
                    {
                        "drugbank-id": "DB00104",
                        "description": "The serum concentration of Brentuximab vedotin can be increased when it is combined with Octreotide"
                    },
                    {
                        "drugbank-id": "DB11932",
                        "description": "The serum concentration of Brentuximab vedotin can be increased when it is combined with Abametapir"
                    },
                    {
                        "drugbank-id": "DB15762",
                        "description": "The serum concentration of Brentuximab vedotin can be decreased when it is combined with Satralizumab"
                    },
                    {
                        "drugbank-id": "DB14845",
                        "description": "The serum concentration of Brentuximab vedotin can be increased when it is combined with Filgotinib"
                    },
                    {
                        "drugbank-id": "DB15982",
                        "description": "The serum concentration of Brentuximab vedotin can be increased when it is combined with Berotralstat"
                    },
                    {
                        "drugbank-id": "DB15258",
                        "description": "The therapeutic efficacy of Brentuximab vedotin can be decreased when used in combination with Imlifidase"
                    }
                ]
            }
        },
        "revision_date": "2023-05-14"
    }
}